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PROBABILITY OF CONCEPTION AFTER FERTILITY COUNSELING AND THE 
ASSOCIATION OF SEXUALLY TRANSMITTED INFECTIONS WITH 
PREGNANCY IN THE LOUSSI STUDY 
Lindsey Adelle Wood 
July 24, 2019 
 
This study interrogated predictors of pregnancy and the effect of a history 
of sexually transmitted infection (STI) on probability of conception among a 
cohort of women seeking fertility counseling (N=170), using multivariable logistic 
regression and Cox proportional hazards models. There were 76 (44.7%) total 
pregnancies. 32 (39.0%) were achieved spontaneously by women who never 
received ART (N=82). Among women who did receive ART (N=88), 35 (39.7%) 
were achieved by ART and 9 (10.2%) achieved spontaneously. Among the full 
cohort (N=170), obesity was a significant negative predictor of pregnancy while 
history of human papilloma virus was a significant negative predictor of time to 
pregnancy. Among those who did receive ART (N=88), ovarian infertility 
diagnosis was a significant positive predictor of pregnancy, relative to other 
infertility diagnoses. History of STI was nonsignificantly associated with 
increased probability of pregnancy in all sub-samples, though this result may be 
confounded by characteristics like coital frequency.  
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A. INTRODUCTION 
The clinical definition of infertility is “the failure to achieve a clinical 
pregnancy after 12 months or more of regular unprotected sexual intercourse” 
[1]. When such a failure occurs, many couples find assisted reproductive therapy 
(ART) an attractive option. These therapies include, but are not limited to, in-vitro 
fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Some treatments 
end successfully, with the patient having an assisted conception and live birth. 
However, some treatments are unsuccessful in that they do not produce a 
conception. In this case, the patient has the option to continue therapy with more 
cycles, or to discontinue treatment for varying reasons, such as the stresses that 
can be induced during treatment or the cost of the treatment.  
 After discontinuation of ART, either successful or otherwise, or even if no 
ART was ever received, there is still a possibility that an infertile patient may 
have a spontaneous conception, meaning that the patient conceived on their own 
while not receiving any form of ART. Varying studies have found spontaneous 
conception rates after ART treatment to be anywhere from 17% to 34% [2-8]. 
These studies, however, vary in their defined population. For example, some 
studies [3-6] only include patients that had live births from IVF or ICSI, while 
others [7, 8] include successful and unsuccessful treatments from ART, while still 
others only include those who had unsuccessful treatment [2] or a specific 
infertility diagnosis [9].
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Fertility in women can be affected by the woman’s history of a handful of 
STIs [10-19]. Chlamydia, specifically, is the major cause of pelvic inflammatory 
disease (PID), which can lead to tubal factor infertility, and can also lead to 
adverse pregnancy outcomes such as ectopic pregnancy via PID, premature 
rupture of the membrane, preterm birth, low birth weight, and stillbirth [10]. Also, 
although it is well known that HPV is the cause of most, if not all, cervical 
cancers, chlamydia is thought to play a significant cofactor role in these 
developments [10]. Gonorrhea can also lead to PID, although higher proportions 
of chlamydia than gonorrhea have been found in women with PID [11]. Likewise, 
gonorrhea has been associated with endometriosis diagnosis, although not as 
associated as chlamydia [12]. Salpingitis (inflammation of the fallopian tubes) 
associated with chlamydia and gonorrhea is causal of tubal infertility [13, 14]. 
Gonorrhea infection is not as strongly associated with tubal infertility as 
chlamydia is [15, 16], and likelihood of conception for any type of infertility is 
higher in those with gonorrhea infection than with chlamydia infection [14]. The 
effects of HPV on infertility are well-established in males, but little is known about 
the effects on infertility in women [17, 18]. It is established, however, that HPV 
infection in women can cause adverse pregnancy outcomes, such as miscarriage 
and the premature rupture of the membrane [18].  The effects of herpes simplex 
virus on male infertility is also well-established, but herpes infection has no 
association with cervical factor infertility [19]. Herpes may, however, be 
associated with PID, although this is not definitive [20]. For all of these reasons, it 
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is somewhat surprising that few studies have included STI history while 
conducting conception analyses among infertile couples.  
The purpose of this study is to determine the effects of STI history on the 
likelihood of achieving pregnancy and on the time to achieve pregnancy among a 
cohort of women seeking infertility treatment, whether or not they received ART 
treatments. Also, predictive models will be produced in order to determine which 
factors predict the likelihood of pregnancy and the time to achieve pregnancy 
among the infertile women.  
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B. SPECIFIC AIMS AND HYPOTHESES 
The primary objective of this study is to analyze numerous factors to 
determine their effects on the probability of achieving pregnancy and to assess 
which factors predict the time to achieve pregnancy among three sub-samples of 
the prospective LOUSSI cohort: 1) the entire prospective cohort of women 
seeking fertility care, 2) the women who have ever received ART treatments, and 
3) the women who have never received ART treatments.  
The specific aims of the study are as follows;  
Specific Aim 1: To estimate the effect of STI history on a) the 
probability of pregnancy and b) the time to pregnancy. Hypothesis: a history 
of STI will be negatively associated with the probability of pregnancy and the time 
to pregnancy among all sub-samples.  
Specific Aim 2: To identify factors which predict a) the probability of 
achieving pregnancy after fertility counseling and b) the time to achieving 
pregnancy. Hypothesis: factors that will predict the probability of pregnancy and 
the time to pregnancy will be age, obesity, AMH levels, unexplained infertility, 
and history of STI. 
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C. BACKGROUND AND SIGNIFICANCE 
 
Fertility Care Definitions 
 There are many terms that should be defined in order to obtain a full 
clinical understanding of fertility. In 2017, the World Health Organization (WHO) 
and the International Committee for Monitoring Assisted Reproductive 
Technologies (ICMART), along with other experts, revised the existing 2009 
International Glossary on Infertility and Fertility Care [1]. As a result, The 
International Glossary on Infertility and Fertility Care, 2017 is an agreement on 
clinical definitions of infertility and other relevant terms [21].  
Before being able to fully understand infertility, three important fertility care 
definitions need to be distinguished: “fertility,” “fecundity,” and “fecundability.” 
“Fertility” is the ability to “establish a clinical pregnancy,” where “clinical 
pregnancy” is a “pregnancy diagnosed by ultrasonographic visualization of one or 
more gestational sacs.” Conversely, “fecundity” is the “capacity to have a live 
birth,” where “live birth” is a birth in which the child is completely extracted from 
the mother after 22 weeks of gestation and shows evidence of live. Further, 
“fecundability” is the “probability of a pregnancy, during a single menstrual cycle 
in a woman with adequate exposure to sperm and no contraception, culminating 
in a live birth.” In brief, “fertility” is the ability to achieve pregnancy, “fecundity” is 
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the ability to achieve a live birth, and “fecundability” is the probability of achieving 
a pregnancy in one menstrual cycle leading to a live birth [21].  
Often interchanged, “infertility” and “subfertility” are defined as “the failure 
to establish a clinical pregnancy after 12 months of regular, unprotected sexual 
intercourse.” This means that any person who has not been preventing 
pregnancy, and has frequent coital activity, but has not achieved pregnancy 
within a year’s time, is clinically infertile. However, the definition also states that 
“fertility interventions may be initiated in less than 1 year based on…age,” 
meaning that providers can offer infertility treatments for women 35 years of age 
or older after only 6 months of trying and failing to achieve a pregnancy [22]. 
Additionally, an infertility diagnosis may not be definite; “sterility” is the term used 
when infertility becomes a permanent state. Infertility can either be a primary or 
secondary diagnosis for either a male or the female partner. One is diagnosed 
with “primary infertility” when he/she has never initiated or been diagnosed with a 
clinical pregnancy before. Conversely, “secondary infertility” is the state of 
infertility in a male whom has successfully initiated a clinical pregnancy or in a 
female who has been diagnosed as clinically pregnant.  
 
Epidemiology of Infertility 
 The prevalence of infertility has proved to be difficult to estimate; the 
estimate can be easily affected by how the condition is being defined or 
diagnosed. One review paper concluded that based on the literature, it is nearly 
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impossible to calculate a prevalence [23]. This is largely due to the inconsistency 
in calculating infertility, especially in calculating the denominators; some of which 
consist of women attempting conception, women who are currently married, 
being ever married, and even all women. However, a 2012 World Health 
Organization study used 277 national, regional, and global surveys on infertility to 
produce the best estimate of prevalence of infertility [24]. The authors greatly 
detailed the definitions of their calculations; in the numerator of primary infertility 
prevalence were women whom were part of an infertile couple, while the 
denominator was women who were a part of infertile couples and a part of fertile 
couples – of which had one successful live birth and have been in the same 
relationship for at least five years. Likewise, in the numerator of the prevalence of 
secondary infertility were women whom were part of an infertile couple, but the 
denominator included women whom were a part of an infertile couple and women 
whom were a part of a fertile couple – of which had one successful live birth 
within the past five years and were in the same relationship five years after their 
first live birth. The authors concluded that the prevalence of primary infertility in 
2010 among women seeking to have a child was 2.7%, 2.0%, and 1.6% in age 
ranges of 20-24 years, 25-29 years, and 30-44 years, respectively. The overall 
primary infertility and secondary infertility prevalence for 2010 was 1.9% and 
10.5%, respectively. In 2010, women in the United States of America had a fairly 
low prevalence of secondary infertility of under 6%, while some countries in 
Eastern Europe and Central Asia had a secondary infertility prevalence of over 
16%. It was also estimated that there are 19.2 million and 29.3 million couples 
  8 
with primary and secondary infertility, summing at 48.5 million couples with 
infertility, globally.  
 Within the United States, infertility among women has decreased from 
1965 to 2010 [25]. A CDC study reported that 11.2%, 8.5% and 6.0% of married 
women ages 15-44 in the United States were infertile in 1965, 1982, and 2006-
2010, respectively. The number of women infertile in 1965, 1982, and 2006-2010 
were 2.96 million, 2.39 million, and 1.53 million, respectively. Between 2006 and 
2010, estimates of primary infertility among married women ages 15-24, 25-29, 
30-34, 35-39, and 40-44 were 7%, 9%, 9%, 25%, and 30%, respectively, 
accounting for 700,000 infertile married women. Additionally, 830,000 married 
women between the ages of 15 and 44 experience secondary infertility between 
2006 and 2010. 
 
Infertility Diagnoses 
 There are many pathophysiology defects by which infertility can arise. In 
the female, defects can occur along any part of the reproductive system, 
including the fallopian tubes, the uterus or the endometrium, and the ovaries. In 
the male, defects of the sperm can arise through a number of causes. The cause 
of infertility in a couple could also be due to unknown causes, by which the cause 
of infertility is deemed as unexplained. This section dives into each infertility 
diagnosis, and the pathophysiology of each. 
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Female: Tubal Factor 
 In the conception process, the role of the fallopian tubes is to transport the 
egg and the sperm, as well as to house a newly fertilized embryo during its first 
stages of development [26]. When the fallopian tubes are damaged, female 
infertility can occur. Tubal factor infertility refers to the blockage or occlusion of 
the fallopian tubes. When this occurs, infertility is potentially caused by 1) sperm 
being unable to fertilize the egg, or by 2) a fertilized egg not being able to reach 
the uterus to be implanted.  Reported prevalence of tubal factor infertility among 
infertile couples in 2003 and 2008 ranges from 12% to 33% [26] and 25% to 35% 
[27], respectively.  
There are several etiologies of tubal factor infertility, but the most common 
source is pelvic inflammatory disease (PID). It has been estimated that in the 
United States, 8% of women between the ages of 16 and 46 are diagnosed with 
PID, and more than 1 million women are treated for PID annually [28]. PID is 
strongly associated with tubal factor infertility, and as PID episodes increase, so 
does the rate of tubal factor infertility; after one, two, and three episodes, tubal 
infertility rates can be up 8%, 19.5%, and 40%, respectively [29].  It should be 
noted that PID is mainly caused by chlamydia infection and gonorrhea infection; 
however, for the purposes of this thesis, these topics are reviewed in a separate 
section.  
Other, less common causes of tubal factor infertility are endometriosis, 
and surgical complications. Although endometriosis can be considered a female 
infertility diagnosis on its own, it can also contribute to development of tubal 
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factor infertility; when pelvic adhesions are present from endometriosis near the 
fallopian tubes, it is possible that distortion occurs in the tubes [26]. Finally, prior 
abdominal surgeries can cause tubal factor infertility by promoting adhesions 
when the epithelial cells of the peritoneum do not regrow correctly [30].  
 
Female: Uterine Factor  
 Regarding reproduction, the uterus plays an imperative role. The uterus is 
where a fertilized egg is implanted, and the uterus remains the home of the 
growing fetus until birth. There are several uterine factors that can inflict infertility 
on a woman, these include congenital factors, fibroids, intrauterine adhesions, 
endometriosis, and other cervical factors.  
 There are several congenital uterine disorders. These disorders are the 
most common genital tract abnormalities in females [28]. The most common 
congenital malformation of the uterus, and the most debated, is septate uterus 
i.e. uterine septum, a condition characterized by the upper wall of the uterus 
protruding into the wall of uterus, thereby creating a divide or septate [31]. 
Although septate uteri have been reported to be associated with recurrent 
pregnancy loss [28, 32], there is insufficient evidence to support the association 
between uterine septum and infertility [32, 33]. 
 Uterine leiomyomata, i.e. myomas or fibroids, are benign tumors. Fibroids 
occur in 20% - 40% of reproductive-aged women, making them the most 
common benign tumors among women of reproductive age [34]. One possible 
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symptom of uterine fibroids is infertility; however, uterine fibroids are typically 
asymptomatic and infertility is a rare symptom [34]. When infertility does occur 
from fibroids, there are several mechanism of occurrence, including but not 
limited to obstruction of the fallopian tubes, distorted or inflamed endometrium, 
and reduced exposure to sperm as a result of a displaced cervix [35]. 
Intrauterine adhesions are also known to affect fertility in women, with 
estimates of 1.5% of infertile women experiencing them [36]. The most common 
symptoms of intrauterine adhesions are menstrual disruptions and infertility [37]. 
Infertility by intrauterine adhesions is caused through the uterine cavity becoming 
partially or completely obliterated from repeated curettage, mainly after abortions 
and delayed removal of the placenta after delivery [36]. Endometriosis is defined 
by the endometrial tissue being present outside of the endometrium, such as in 
the pelvic peritoneum or the ovaries [38]. Endometriosis affects 6-10% of all 
females [38] and 5-15% of reproductive-aged women [28], but reaches to 35-
50% in women with pain or infertility [38]. Symptoms of endometriosis include 
chronic pelvic pain, abnormal uterine bleeding, and infertility [28]. Infertility 
caused by endometriosis is mainly due to the resulting inflammation, which can 
lead to dysfunction in ovulation, sperm phagocytosis, impaired fertilization, and 
problems with implantation [39]. Although the origins of endometriosis are widely 
unknown, the most accepted theory on the pathogenesis of endometriosis is 
Sampson’s theory of retrograde menstruation: during menstruation, endometrial 
tissue flows up the fallopian tubes and into the peritoneal cavity [40].  Sampson’s 
theory is also supported by his observation of menstrual blood leaving through 
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the fallopian tubes and his findings of endometrial tissue in the lumen of some of 
his female patients with endometriosis [40]. However, Sampson’ theory has 
faced questioning due to the fact that most women have retrograde 
menstruation, but only 6-10% of women are diagnosed with endometriosis [38]. 
There are now a number of theoretical pathogeneses of endometriosis, including 
genetic factors, immune factors, and some environmental factors.   
The cervix is mainly responsible for keeping a fetus in the uterus until birth 
[41]. The mucus produced by the cervix changes during the menstrual cycle, and 
the production of abnormal mucus has been thought to inhibit the ability of sperm 
to enter the uterus [42]. However, cervical factors are rarely diagnosed as the 
main cause of infertility [43, 44]. This is largely due to the fact that the diagnostic 
test for cervical factors, the post-coital test, is unreliable and does not predict 
infertility [43, 44]. The test is no longer recommended in infertility evaluations 
[43].  
 
Female: Ovarian Factor  
 The primary function of the ovaries is to produce a mature follicle that will 
release an egg, in a process called ovulation. Ovarian factor infertility is 
diagnosed when a woman does not ovulate, or experiences anovulation. This 
ovarian dysfunction accounts for 40% of female infertility [45]. There are several 
causes of ovarian factor infertility, and the World Health Organization categorizes 
ovulation disorders into three groups [46].  
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Group I consists of women who have hypogonadotropic (secondary) 
hypogonadism, which is most present in women of low BMI and women who 
exercise excessively [47]. These two factors lead to the reduced production of 
gonadotrophin releasing hormone by the hypothalamus, which then results in 
reduced production of luteinizing hormone (LH) and follicle stimulating hormone 
(FSH) by the pituitary gland [47]. The lack of these hormones ultimately leads to 
the absence of menstruation, or amenorrhea [47]. 
Group II includes women of whom have hyperprolactinaemic 
amenorrhoea – or hyperprolactinaemia – or polycystic ovarian syndrome 
(PCOS). Hyperprolactinaemia results when the pituitary gland produces a 
reduced amount of LH and FSH, caused by a microadenoma on the pituitary 
gland [47]. The next Group II diagnosis, PCOS, is present in 5-10% of 
reproductive aged women [46] and accounts for 70% of infertility due to 
anovulation [47]. PCOS arises when the ovary/ovaries produce an excess 
amount of androgen, which results in several pre-ovulatory follicles to be formed. 
When these follicles don’t respond to FSH, no dominant follicle is produced [47], 
and the multiple small follicles remain [46]. PCOS is most common in women in 
their late teens to early 20s, and is often present with excessive hair growth 
(hirsutism), irregular periods, acne, and obesity [47].  
Women in Group III are those women of whom have hypergonadatrophic 
(primary) hypogonadism, resulting in ovarian failure or premature menopause. 
Primary hypogonadism results from the ovaries not producing enough estrogen 
  14 
and producing higher levels of LH and FSH [48]. The resulting premature 
menopause makes the patient incapable of ovulating, and therefore, infertile.  
Another ovarian factor that can lead to infertility not mentioned in the WHO 
classifications is diminished ovarian reserve. Diminished ovarian reserve refers 
to a reduced number of and/or reduced quality of oocytes in reproductive aged 
women who have regular menstruation [45]. Women with diminished ovarian 
reserve generally have lower serum antimüllerian hormone (AMH) 
concentrations, which is associated with poor response to ovarian stimulation 
and poor IVF pregnancy outcomes [45]. It should be noted however, that an AMH 
test with poor results does not imply the inability to conceive [45]. 
 
Male Factor Infertility 
 In reproduction, the role of the male is to have enough sperm ejaculated in 
order to fertilize the female’s egg. Male factor infertility is solely responsible for 
20% of infertile couples, and contributes to an additional 30-40% of infertile 
couples [49]. Most male infertility (90%) is due to poor sperm quality, low sperm 
counts, or both [50]. Males with oligozoospermia present semen that consists of 
low sperm concentration and low sperm motility. Even more dramatic, 
azoospermia is when semen has absolutely no sperm. There are two ways 
azoospermia can be caused. Obstructive azoospermia is a result of blockage in 
the epididymis or the ejaculatory ducts, therefore preventing sperm to be present 
in the semen [51]. Non-obstructive azoospermia is caused by a testicular 
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dysfunction, which is the leading cause of disturbed spermatogenesis [51]. Some 
cases of non-obstructive azoospermia can include hypergonadotrophic 
hypogonadism, which is characterized by higher concentrations of FSH being 
present [51]. Conversely, hypogonadotrophic hypogonadism, characterized by 
having lower concentrations of FSH and LH, is caused by pituitary or 
hypothalamic diseases [51]. When a male presents with normal sperm, infertility 
could potentially be caused by ejaculatory problems, such as retrograde 
ejaculation and even the lack of ejaculation [49]. Further, there is evidence of 
male infertility having a fetal origin, either by genetic mutations leading to sexual 
development disorders, or by fetal chemical exposure leading to disruption of 
testes development [52]. 
 
Unexplained Infertility 
 The prevalence of unexplained infertility ranges from 8% to 37% [53]. 
Couples are diagnosed with unexplained infertility when both partners present 
with normal fertility evaluations, meaning that there is not one specific 
abnormality identified to be causing their infertility. Guidelines do exist on 
diagnosing unexplained infertility; the initial evaluation consists of a semen 
analysis, ovulation analysis, and evaluations of the uterine cavity and of tubal 
patency [43, 44]. When all these evaluations return normal results, unexplained 
infertility is diagnosed to the couple. However, unexplained infertility prevalence, 
and even the existence of the term itself, remains debated. This is mainly 
because the process of diagnosing unexplained infertility, even with said 
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guidelines, is questionable. Firstly, there still remain areas of reproductive 
science for which there are no testing procedures, meaning that a true infertility 
cause may not currently be possible of being diagnosed [53]. Further, when put 
to clinical practice, fertility evaluations vary widely among physicians and are not 
consistently executed, potentially leading to misdiagnosis [54]. Unexplained 
infertility can be a frustrating diagnosis to couples who are actively trying to 
conceive. Unlike the other diagnoses mentioned prior, there is no clear-cut 
answer to the problem, and therefore no clear-cut answer on how to approach 
treatment.  
 
Treatments for Infertility 
 With so many causes of infertility, there is not a one-size-fits-all treatment. 
Certain infertility diagnoses qualify for some treatments over others. For 
example, some diagnoses may only require lifestyle changes to increase the 
likelihood of conception, while others may require assisted reproductive 
technology (ART). This section explores the varying infertility treatments, how 
they work, and which diagnoses are appropriate for each treatment. All 
information in this section can be referenced to the National Institute for Health 
and Care Excellence (NICE) Clinical Guidelines on infertility treatments [46]. 
 
Lifestyle Changes and Expectant Management  
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 Lifestyle changes are the preferred method of treatment for women of the 
Group I ovulation disorders. As mentioned in a prior section, secondary 
hypogonadism is present in women with low BMI or who exercise excessively. 
For these women, just increasing their BMI, normalizing their exercise, or both 
can increase their likelihood of conceiving.  
 Expectant management is the act of timing sexual intercourse with 
ovulation, and of increasing coital activity. Expectant management is the 
preferred method of treatment for couples that have an unexplained infertility 
diagnosis. It is recommended to these couples to try to conceive for at least 2 
years with expectant management. If after 2 years of expectant management, 
these couples have still failed to conceive, then the couple is offered IVF 
treatment.  
 
Male Factor Treatments 
 As mentioned prior, there are a number of etiologies for male factor 
infertility, of which the main treatment options consist of varying medical and 
surgical options, as well as IVF and ICSI, which will be discussed in a later 
section. For men with hypogonadotrophic hypogonadism, gonadotrophin drugs 
are offered. Men with obstructive azoospermia have the option to consider 
surgical repair of the blocked duct, but only as an alternative to sperm recovery 
and IVF. Ejaculatory disorders can be treated by a number of options, such as 
penile electrovibration and transrectal electroejaculation for anejaculation, 
  18 
varying drugs for retrograde ejaculation, and surgical sperm retrieval. IVF/ICSI 
are considered when all other treatments fail.  
 
Assisted Reproductive Technologies: Ovulation Induction  
 Ovulation induction therapy is used for those with ovulatory disorders to 
help stimulate the ovaries to produce at least one egg, but usually more than 
one. There are several routes to induce ovulation, but they vary by ovulatory 
diagnosis. As mentioned prior, there are three groups of ovulation disorders. Of 
the three, ovulation induction can only be beneficial for those women in Groups I 
and II. For women with hypogonadatrophic hypogonadism (Group I), the first 
recommendation is to change their lifestyle factors, such as increasing their 
weight and BMI, as well as moderating strenuous exercise. Normalizing these 
lifestyle factors can increase their chances of ovulation and even conception. 
Doctors also offer these Group I women hormone pills to induce ovulation. For 
women with PCOS (Group II), those with a BMI greater than or equal to 30 are 
advised to lose weight, as lowering their BMI could restore their ovulation. For 
those without a severe BMI, it is recommended that hormone pills be offered, 
including an anti-oestrogen (clomiphene citrate), an insulin sensitizer (metformin 
hydrochloride), or a combination of both. Those women who do receive 
clomiphene citrate and/or metformin hydrochloride should not take the oral 
medication for longer than six months.   
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Assisted Reproductive Treatments: Intrauterine Insemination 
Intrauterine insemination (IUI) consists of inserting sperm directly into the 
uterine cavity around the time of ovulation. This treatment can be performed with 
or without ovulation induction. When ovulation induction is used, the insemination 
process does not occur until after the induction has occurred. Women take 
hormone tablets for several days. Then, if during an ultrasound, there is at least 
one, but no more than three developed follicles, induction occurs. Insemination 
then occurs within the next day to 36 hours.  
In the past, IUI has been a treatment for the infertility diagnoses of mild 
endometriosis, mild male factor infertility, and unexplained infertility. However, 
the most recent NICE guidelines now recommend the following: 1) IUI with no 
ovulation induction should be given to those of whom cannot have vaginal 
intercourse, such as those with psychosexual disorders, same-sex couples, and 
those with conditions of which require special consideration (HIV positive males); 
2) for those who have yet to conceive after 6 cycles of IUI, another 6 cycles of IUI 
without ovulation induction should be offered before offering IVF; and 3) for those 
with diagnoses of mild endometriosis, mild male factor infertility, and unexplained 
infertility, IUI should not be offered, but rather continue to attempt to conceive for 
at least two years before considering IVF.  
 
Assisted Reproductive Treatments: In Vitro Fertilization and Intracytoplasmic 
Sperm Injection  
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 In Vitro Fertilization is an ART procedure that consists of the fertilization of 
eggs with sperm outside of the body. There are seven total stages of IVF, of 
which some are not always used. In general, the process consists of stimulating 
the female’s ovulation, an ovulation trigger, egg and sperm retrieval, and embryo 
replacement. Stimulating ovulation results in eggs being produced, while 
ovulation trigger results in the initiation of ovulation. The eggs and sperm are 
then retrieved, and fertilization takes place in the laboratory. A few days after 
fertilization, the now embryos are placed in the female’s uterus. Patients are 
sometimes offered hormones before ovulation stimulation and after embryo 
replacement to help with the preparation of the IVF process and with the early 
development of the embryo. In general, IVF acts as the last resort treatment 
option, only being used when the preferred treatment option for a diagnosis has 
failed. IVF is offered to patients of whom the following preferred methods have 
failed: 1) expectant management for unexplained diagnoses, 2) ovulation 
induction for ovarian disorders, 3) treatment of endometriosis, 4) treatment for 
tubal disease, and 5) treatment for identified male factor infertility. The infertility 
diagnoses that most warrant IVF, and of which IVF is the preferred treatment, are 
those of severe tubal disease and severe male factor.  
 Intracytoplasmic Sperm Injection is often used in tandem with IVF. ICSI 
involves the insertion of a single sperm into an egg during a typical IVF process. 
The benefit comes in selecting the specific sperm, usually the best individual 
sperm, that will fertilize the egg. For this reason, ICSI is mainly used when 
severe male infertility is involved, as the likelihood of fertilization in vitro is still 
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very low. These disorders include low sperm quality and obstructive and non-
obstructive azoospermia. ICSI is also an option for couples of other diagnoses of 
whom regular IVF has failed. However, ICSI with IVF only increases the 
likelihood of fertilization, and does not increase the overall conception rate any 
better than IVF alone. 
 
Infertility and Spontaneous Conception  
 Couples who have infertility diagnoses can still sometimes conceive 
naturally, regardless of whether they have received ART. Among the literature of 
infertile couples, varying studies have found spontaneous conception rates to be 
anywhere from 11.2% to 80% [55, 56]. These rates, however, are sometimes 
crude rates, while other times are ongoing or cumulative rates. Also, studies vary 
highly in their defined population. For example, some studies only include 
patients that had prior live births from IVF or ICSI, while others include successful 
and unsuccessful treatments from ART, while still others only include those who 
had unsuccessful treatment or those of whom remain untreated. Spontaneous 
conception and live birth rates by study population are shown in Table 1. It is 
difficult to interpret these conception rates relative to the general infertile 
population, as each rate is very specific in its rate type and in its population. 
Further, some studies only report live birth rates; however, these rates can be 
thought of as the minimum conception rate, as there have to be at least as many 
conceptions as there are live birth. 
  
 
Table 1: Spontaneous Conception and Live Birth Rates Among Infertile Couples  
Population Authors Year Outcome Rate N  
currently receiving ART 
Vardon et al. 1995 spontaneous conception 11.2% 594  
Pinborg et al. 2009 
first live birth from 
spontaneous conception 
18.2% 817  
currently receiving ART with 
unexplained infertility 
Brandes et al. 2011 spontaneous conception 60.2% 437  
prior successful ART 
Shimizu et al. 1999 
subsequent spontaneous 
conception 
18.0% 142  
Hennelly et al. 2000 
subsequent spontaneous 
conception 
20.7% 513  
Kupka et al.  2003 
subsequent spontaneous 
conception 
80.0% 32  
Ludwig et al. 2008 
subsequent spontaneous 
conception 
20.0% 695  
Troude et al. 2012 
subsequent live birth from 
spontaneous conception 
17.0% 1320  
Lande et al. 2012 
subsequent live birth from 
spontaneous conception 
21.6% 102  
Marcus et al. 2016 
subsequent spontaneous 
conception 
27.3% 307  
prior unsuccessful ART 
Osmanagaoglu et al. 2002 
live births from spontaneous 
conception 
11.5% 200  
Kupka et al.  2003 spontaneous conception 47.0% 194  
Troude et al. 2012 
live births from spontaneous 
conception 
24.0% 814  
Marcus et al. 2016 
subsequent spontaneous 
conception 
35.4% 96  
untreated by ART 
Collins et al. 1995 
live births from spontaneous 
conception 
38.2% 2198  
Snick et al. 1997 spontaneous conception 72.0% 342  
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There are few studies in which the study population consists of infertile couples 
who remain untreated by ART. However, spontaneous conceptions rates among 
untreated women are relevant to this study, as 82 (48.2%) of the LOUSSI study 
population used in this thesis never received any form of ART. Of the three 
studies of conception rates among untreated couples, two utilized Cox 
proportional hazards models. Resulting cumulative live birth rates were 38.2% at 
36 months [57] and 72.0% at 36 months [58]. The median time to conceptions 
resulting in live births were 10.4 months and 8.1 months, respectively. The 
remaining study utilized a Kaplan-Meier method to determine a one-year 
cumulative pregnancy rate at 9.1% [59].  This would be equivalent to a 24.9% 
pregnancy rate after 36 months, assuming 9.1% rate per year. At first glance, 
these cumulative rates seem drastically different; however, cumulative pregnancy 
rates increase with time, so it does make sense that the shorter follow up will 
have the lowest cumulative rate.  
The number of studies that assess spontaneous conception rates among 
infertile women who are actively, but inconsistently receiving ART is also limited. 
Among the three identified, one study found a 60.2% spontaneous conception 
rate in 5 years among women with unexplained infertility and currently receiving 
ART [9]. Conversely, a separate 5-year prospective cohort study  found the live 
birth rate following spontaneous conceptions to be 20.7% [60]. However, these 
births belonged to only 18.2% of the women in the study, meaning that some 
women spontaneously conceived and delivered twice within 5 years of initiating 
ART. An even more dramatically lower rate is found in a study that is written in a 
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language other than English, but the abstract reports that this retrospective study  
found that 11.2% achieved a spontaneous conception among women in an IVF 
program [55]. However, the follow-up time is unknown. The 5-year spontaneous 
conception rates of these studies vary from 18.2% to 60.2%. However, the 
highest conception rate was among women with an unexplained infertility 
diagnosis, which, as will be shown in a later section, is a diagnosis that usually 
results in the highest likelihood of conception.  
 Most literature regarding conceptions among infertile populations is 
conducted among those with prior successful ART treatment. Crude rates are 
most often reported, however, and the follow-up times vary in each study. For 
example, in one study with a two-year follow-up of women who had prior 
successful IVF/ICSI, 20.7% had a subsequent spontaneous conception [3]. 
Another study, which included 7 to 9 years of follow up time, reported a 
cumulative live birth rate of 17% after a prior successful IVF/ICSI [8]. Further, an 
internet survey study included varying times of follow up and reported 27.3% 
spontaneous conception rate after successful IVF/ICSI [7]. This particular study, 
however, may be an overestimation of the true rate, as those women who did 
conceive are conceivably more likely to respond to the online survey. Other 
studies, with follow-up times between the aforementioned 2 and 9 years, report 
spontaneous conception or live birth rates after a successful IVF/ICSI treatment 
at 14.2% [56], 18% [6], 20% [4], and 21.6% [5]. The literature on subsequent 
spontaneous conceptions after a successful IVF/ICSI treatment show rates 
between 14.2% and 27%, with varying follow up times. When mentioned, the 
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majority of spontaneous conceptions in all of these studies occurred within the 
first two years of follow up; this means that after having a successful IVF/ICSI, 
those who will achieve a subsequent spontaneous conception will most likely do 
so within the next two years.  
 Few studies can be identified that assess spontaneous conception rates 
after failed ART treatments. The internet study mentioned previously also 
analyzed spontaneous conceptions among women who had unsuccessful 
IVF/ICSI treatments and decided to discontinue treatments [7]. The authors 
report that 35.4% of these women achieved spontaneous conception. Another 
study  included only women who were younger than 37 years, and reported a live 
birth (resulting from spontaneous conception) rate of 11.5% after discontinuing 
failed ICSI treatments [61]. Other studies have reported a 14.2% [56] 
spontaneous conception rate among those who discontinued IUI or IVF 
treatments, and a 24% [8] spontaneous conception rate after discontinuing 
unsuccessful IVF treatments. Although these studies reported on the same 
general population, spontaneous conception rates varied widely from 11.5% to 
35.4%. It should be noted, however, that the largest rate is reported in the 
internet survey study, which could potentially be an overestimation of the true 
spontaneous conception rate, as those women who did conceive would be more 
likely to respond than those who did not conceive.  
 
Predictors of Fertility 
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 There are a number of factors that are associated with overall fertility and 
the likelihood of conception. Accounting for these factors is imperative for 
comparing likelihoods of pregnancy across infertile groups. The purpose of this 
section is to review the literature on several important predictors of fertility that 
should be considered for inclusion in conception models.  
 
Obesity 
Overweight, or pre-obesity is defined by the CDC and the WHO as having 
a BMI between 25.0 to 29.9, whereas obesity is defined as a BMI of 30.0 or 
greater [62, 63]. In the United States, roughly 32% of women (ages 20 to 39 
years) are obese. For reproductive-aged women, obesity can have major impacts 
on their fertility, including problems with ovulation, fertilization, and uterine 
problems.  
One of the proposed mechanisms on how obesity can affect ovulation is 
through insulin resistance; having insulin resistance can lower the amount of sex 
hormone-binding globulins produced in the liver, resulting in increased amounts 
of free androgens and free estrogens. This increase of free estrogens ultimately 
leads to an increase of FSH released from the pituitary gland, which causes 
impaired ovulation [64]. It has also been shown that women who have irregular 
menses are four times more likely to be obese than women who have regular 
menses [65]. There also seems to be a dose-dependent relationship between the 
percentage of anovulatory cycles a woman has and her BMI; for women less 
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than 20% overweight, 20-49% overweight, 50-74% overweight, and more than 
74% overweight, the percent of anovulatory was 2.6, 4.0, 5.8, and 8.4, 
respectively [65]. The insulin resistance associated with obesity is also a main 
factor in the development of PCOS; as mentioned prior, PCOS is caused by 
excess androgen, leading to multiple follicles to be formed on the ovaries [47]. 
Further, one study found that women with PCOS were nearly twice as likely to be 
overweight than those women without PCOS, with rates of BMIs of 25 or more at 
60.6% and 34.8% (p-value < 0.001), respectively [66].  
Fertilization can also be a problem for obese women. One study found 
that among IVF recipients, women with a BMI between 35 and 39.9, and women 
with a BMI of 40 or higher, had significantly fewer normally fertilized oocytes 
(mean of 7.7 and 7.6, respectively), compared to the referent group women of 
BMI of 18.5 to 24.9 (mean of 9.3) (p-value < 0.03) [67]. The study also showed 
that when compared to women with a BMI between 18.5 and 24.9, women with 
BMIs between 30 and 34.9, between 35 and 39.9, and 40 or greater had 
significantly lower odds of achieving conception on their first IVF cycle, with ORs 
of 0.67 (95% CI: 0.46 – 0.97), 0.56 (95% CI: 0.34 – 0.93) and 0.50 (95% CI: 0.31 
– 0.82), respectively [67]. There was also a clear dose-dependent relationship 
between odds of conception during the first IVF cycle and BMI, suggesting that 
an increasing BMI decreases the likelihood of fertilization.  
Being obese can also have detrimental effects on the functioning of the 
uterus. One study found that among women receiving healthy donor eggs, a 
negative linear trend was found between implantation rates and higher BMI (p-
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value = 0.008) [68]. Likewise, when comparing women with a BMI of 25 or 
greater with women of a BMI of less than 25, those who were overweight had 
significantly lower odds of conceiving, with pregnancy rates of 38.3% and 45.5%, 
respectively (p-value = 0.002), and an OR of 0.85 (95% CI: 0.76–0.95) [68]. 
Obesity can also affect the effectiveness of ART treatments. For instance, 
one study found that among women receiving ovulation induction, there was a 
significant correlation between weight and the needed dose for conception to 
occur (p-value < 0.001) [69]. For women receiving IVF treatments, BMI has been 
shown to significantly decrease the odds of conception, with an OR of 0.843 
(95% CI: 0.73 – 0.97) for a one-unit increase of BMI [70]. Likewise, a meta-
analysis found that when comparing women with a BMI of 25 or greater to 
women with a BMI of less than 25, those who were overweight had significantly 
lower odds achieving pregnancy (OR = 0.71, 95% CI: 0.62 – 0.81) [71].  
Based on the evidence, it is clear that obesity negatively affects all 
aspects of fertility, including the efficacy of ART treatments. Lower BMI, at or 
below the normal range, can greatly increase the likelihood of both spontaneous 
and ART-related conception by resulting in healthy functioning reproductive 
organs and normal hormone levels. 
 
Smoking 
 Cigarette smoking is well-known to be associated with a number of 
diseases, including infertility. However, 20.7% of reproductive aged women in the 
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United States are smokers [72]. One meta-analysis found that women who were 
smokers had higher odds of experiencing infertility than those women who were 
not smokers (OR = 1.60, 95% CI: 1.34 – 1.91) [73]. Smoking has the ability to 
affect all facets of fertility, including ovarian and fallopian tube function, 
fertilization, embryo development, implantation, and even miscarriage [74, 75]. It 
has been shown that when comparing age-matched smokers to non-smokers, 
ovarian reserve is significantly lower in the smokers (p-value < 0.05), with an 
increased OR for diminished ovarian reserve of 2.8 (95% CI: 1.2 – 7.99) [76]. 
Smoking is also detrimental to fallopian tube functioning, causing a reduced 
blood flow [74] and an impaired ability to transfer oocytes [74, 75]. One study 
found that women who smoke more than 20 cigarettes per day had four times the 
odds of ectopic pregnancies, compared to women who had never smoked (OR= 
3.9, 95% CI: 2.6 – 5.9), concluding that transfer of oocytes to the uterus by the 
fallopian tubes is reduced due to cigarette smoking [77]. Implantation is also 
impaired as a result of smoking; in one study comparing light smokers (0 – 10 
cigarettes per day) to heavy smokers (11 – 20 cigarettes per day) using donor 
oocytes, the light smokers had a significantly higher pregnancy rate than the 
heavy smokers, with pregnancy rates of 52.2% and 34.1%, respectively (p-value 
= 0.02) [78]. The results from this study showed that when using a healthy donor 
oocyte, implantation is higher among light smokers than heavy smokers.   
 Cigarette smoking can have a detrimental effect on conception success 
while receiving ART treatments. Two meta-analyses found associations between 
smoking and lowered ART conception rates. The first found that smokers had 
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33% lower odds of conceiving per IVF cycle than non-smokers (OR = 0.66, 95% 
CI: 0.49 – 0.88) [73]. The second  found that non-smokers had 79% higher odds 
of conceiving during the first IVF attempt than smokers (OR = 1.79, 95% CI: 1.24 
– 2.59) [78]. Finally, another study showed via multivariable analysis, that women 
who have ever smoked had a higher risk of unsuccessful IVF (RR = 2.71, 95% 
CI: 1.37 – 5.25) [79]. This study also showed a dose-response to smoking, as 
each additional year of smoking increased the risk of having no pregnancy by 9% 
(RR = 1.09, 95% CI: 1.0 – 1.16) [79].  
 Based on the current evidence of smoking and infertility, it is clear that 
cigarette smoking is harmful to fertility through more than one pathway. 
 
Ovarian Reserve – Follicle Stimulating Hormone and AntiMüllerian Hormone 
Levels 
 Ovarian reserve refers to a woman’s potential to reproduce, as related to 
how many oocytes and the quality of the oocytes she contains [80]. Diminished 
ovarian reserve (DOR) refers to reproductive aged women of whom, when 
compared to other women of the same age, have lower ovarian stimulation and 
fecundity [80]. Follicle stimulating hormone (FSH) and antimüllerian hormone 
(AMH) are two measures that are often used to estimate ovarian reserve. 
 FSH levels vary throughout the menstrual cycle, and testing should occur 
between the first and fifth day; during this time, normal FSH levels are below 10 
mIU/mL [81]. However, increased FSH levels during this time indicate DOR [80]. 
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In one longitudinal cohort study, 437 couples with unexplained infertility were 
followed between two and eight years, while observing for any pregnancy [9]. Of 
the 437 couples, only 81 couples did not conceive. When comparing those 
couples who did conceive against those couples who did not conceive, female 
FSH levels were significantly lower in those who did conceive (p-value = 0.02). 
However, in a study of older women of reproductive age (30 – 44 years), those 
with high serum and urinary FSH levels did not result in a significantly different 
pregnancy prediction after 6 cycles of attempt or after 12 cycles of attempt [82]. 
The contradicting results of whether FSH levels can predict pregnancy chances 
most likely comes from the efficacy of the FSH test, which is known to have a 
high specificity, but a low sensitivity [80]. However, the test is still used, as it has 
a high positive predictive value, regardless of its simultaneous low negative 
predictive value [80].  
 Levels of AMH vary throughout a woman’s lifetime; levels rise in younger 
years, and typically peak around age 25, after which, levels decline until 
becoming virtually zero a few years before menopause [80]. AMH is independent 
of the menstrual cycle and can therefore be tested at any day of the cycle [80]. 
Depending on the woman’s age, normal AMH levels range between 0.5 ng/mL 
and 2.7 ng/mL [81]. Lowered AMH levels are clinically indicative of DOR. In one 
study of women receiving IVF/ICSI treatments, women who achieved live births 
as a result of treatment had significantly higher AMH levels than those women 
who did not achieve live births (p-value = 0.001) [83]. Likewise, in women 
receiving IUI treatments, those who achieved pregnancy had significantly higher 
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AMH levels than those women who did not achieve pregnancy (p-value = P = 
0.0004) [84]. Clinically, AMH testing is the most relied-upon ovarian reserve 
testing, as it is the most sensitive and is capable of predicting ovarian response 
during ART treatments [80].  
 
Sexually Transmitted Infections  
 STIs such as Chlamydia trachomatis (chlamydia) and Neisseria 
gonorrhoeae (gonorrhea) can contribute to reduced fertility in women. It is 
surprising, then, that to the best of my knowledge, no studies assessing 
characteristics associated with conception among infertile populations include 
STI history in their models. The STIs reviewed here are the only STIs reported in 
the medical histories of the participants of the current thesis.  
 
Chlamydia trachomatis 
The mechanism behind the association between Chlamydia trachomatis 
(chlamydia) and infertility is through pelvic inflammatory disease (PID). PID is an 
infection of the uterus, fallopian tubes, and pelvic structures, usually caused by 
surgery or pregnancy [10]. However, chlamydia is the major cause of PID that is 
not associated with pregnancy nor surgery [10], and is responsible for 50% of all 
PID cases [85]. PID increases the risk of tubal infertility; with one episode of PID, 
the relative risk of tubal infertility is roughly 10%, and each repeat PID episode 
nearly doubles the risk of tubal infertility [86, 87]. For example, women with two 
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PID episodes have a 20% higher relative risk of tubal disease, and nearly a 40% 
higher relative risk after the third episode. Further, another study found 
associations between chlamydia antibodies and tubal factor infertility [88]. 
Another study found that among reproductive-aged women, those with chlamydia 
infection had significantly increased odds of infertility, nearly 10 times as high as 
those with no chlamydia infection (OR = 9.985, 95% CI: 4.70 – 20.63) [11]. 
Likewise, it has also been shown that chlamydia antibodies are more frequent in 
women with infertility and tubal damage than in women with infertility and no 
tubal damage (p-value < 0.0001) [16].  
 
Neisseria gonorrhoeae 
Similar to chlamydia, Neisseria gonorrhoeae (gonorrhea) can also cause 
PID [12]. However, gonorrhea is much less common in women with PID than is 
chlamydia [12], with only 10-19% of PID cases being attributed to gonorrhea 
infection [85]. Although gonorrhea infection can also lead to the same tubal factor 
infertility, tubal factor infertility is much more of a risk among those infected with 
chlamydia. One study found no significant difference of gonorrhea infection 
between women with infertility and tubal damage, and women with infertility and 
no tubal damage [16]. Similarly, another study found that women with gonorrhea-
associated PID were much less likely to experience adverse fertility outcomes 
than those with chlamydia-associated PID [14].  
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Human Papilloma Virus and Herpes Simplex Virus  
Though effects of HPV on infertility are well-established in males, there is 
little evidence demonstrating any effect of Human Papilloma Virus (HPV) and of 
Herpes Simplex Virus (HSV) on infertility in women [17, 18]. It is established, 
however, that HPV infection in pregnant women can cause adverse pregnancy 
outcomes, such as miscarriage and the premature rupture of the membrane [18]. 
Similarly, the effect of HSV on male infertility is also well-established; however, 
HSV infection has no association with cervical factor infertility [19]. HSV may, 
however, be associated with PID, although this is not definitive [20]. 
 
Caffeine  
 Studies assessing the effects of caffeine on pregnancy have varying 
results, keeping the association between the two in current debate. Most studies 
of women receiving ART treatments show no association between caffeine and 
the likelihood of conception. One study found no linear trend between current 
caffeine consumption and pregnancy among women receiving IVF treatments (p-
value for trend = 0.74) [89]. Two more studies report similar findings, with no 
association between current caffeine consumption and pregnancy among ART 
recipients [90], nor between caffeine consumption the year prior to treatments 
and pregnancy among ART recipients [91], even with the median caffeine 
consumption of 456 mg per day and 125 mg per day, respectively. Although 
studies among women receiving ART treatments report consistent findings, 
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studies conducted among women not receiving ART treatments seem to report 
findings that are rather inconsistent. One study found that an increased number 
of cups of coffee per day (p-value for trend = 0.003), as well as an increased 
amount of caffeine per day (p-value for trend = 0.001), had significant negative 
trends with increased time to pregnancy [92]. The study also found that women 
who consumed more than 500 mg per day of caffeine were 1.45 times the odds 
(95% CI: 1.03 – 2.04) to take at least 9.5 months to conceive than women who 
drank 100 mg per day or less of caffeine [92]. However, another study conducted 
among women not receiving ART treatments found that, for increased caffeine 
consumption and achieving conception, the adjusted ORs suggested a general 
negative trend with increasing caffeine consumption; however, none of the ORs 
were significant, and therefore, there was no significant association between 
increased caffeine consumption and pregnancy [93].  
 The majority of evidence suggests that caffeine consumption has little to 
no effect on the likelihood of pregnancy. However, even with very few studies 
reporting associations, the association between caffeine and pregnancy cannot 
be entirely ruled out, but it should be noted that caffeine may be a proxy measure 
for other behaviors or dietary factors and residual confounding is likely a problem 
in most studies. 
 
Alcohol  
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 The effects of alcohol on pregnancy remain in question, as varying studies 
report conflicting results. Some report that there is a negative association 
between how much one drinks and her likelihood of pregnancy, while others 
report that there is no association.  
In a case-control study  of 20 to 40 year old women, no significant linear 
trend between increased number of drinks consumed per week and trouble 
achieving pregnancy was found [94]. There was also no association with 
pregnancy when separate drinks were analyzed; when compared to having no 
drinks per week, the ORs for having more than 5 drinks of wine, beer, and spirits 
was 1.16 (95% CI: 0.72 – 1.88), 1.06 (95% CI: 0.82 – 1.37), and 1.44 (95% CI: 
0.84 – 1.64), respectively.  
However, a longitudinal study of reproductive aged women did find 
significant associations between alcohol and conception when assessing the 
women who were non-smokers [93]. Women who drank 1 to 12 grams, 13 – 90 
grams, and greater than 90 grams of alcohol per week had less odds of 
conceiving than women who did not drink at all, with ORs of 0.43 (95% CI: 0.25 – 
0.76), 0.40 (95% CI: 0.21 – 0.77), and 0.28 (95% CI: 0.20 – 2.15), respectively. 
Although the group of women who drank more than 90 grams of alcohol per 
week did not result in a significant result due to a small sample size within this 
group, the results do show a negative dose response relationship between how 
much a woman drinks and her likelihood of pregnancy.  
Further, one study found significant associations between amount of 
alcohol consumed through the week and infertility diagnoses [95]. Moderate 
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drinkers (100 grams or less) and heavy drinkers (more than 100 grams) had 
higher odds of having an ovulatory factor infertility diagnosis than nondrinkers, 
with ORs of 1.3 (95% CI: 1.0 – 1.7) and 1.6 (95% CI: 1.1 – 2.3), respectively. 
Similarly, moderate (OR = 1.6, 95% CI: 1.1 – 2.3) and heavy drinkers (OR = 1.5, 
95% CI 0.8 – 2.7) had higher odds of having endometriosis as their infertility 
diagnosis than nondrinkers.  
Although the exact relationship between alcohol consumption on 
conception is still under investigation, it is accepted that alcohol consumption is 
not beneficial for those who are trying to conceive. For this reason, and for the 
reason of conflicting literature, alcohol consumption should be included when 
modeling likelihood of conception.  
 
Primary vs. Secondary Infertility  
 Most studies that analyze the likelihood of conception find no association 
with having at least one prior parity [2, 4, 6, 8, 9, 56, 60]. There are two studies, 
however, that found associations of parity and likelihood of conception. The first 
found that among infertile couples remaining untreated by ART, live birth rates 
were positively associated with secondary infertility (HR = 1.83; 95% CI: 1.24 – 
2.69) [57]. Similarly, the next study found that untreated couples with primary 
infertility were achieving spontaneous conception slower than those couples with 
secondary infertility (HR = 0.71, 95% CI: 0.56 – 0.90) [59]. Presumably, if a 
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couple is fertile enough to conceive once, they should be more likely to conceive 
than couples who have failed to ever achieve conception.  
 
Duration of Infertility  
 Several studies have found significant associations between how long a 
couple experiences infertility and the likelihood of conception and live births. 
Across these analyses, varying durations are compared to estimate likelihood of 
pregnancy. One study found that among untreated couples, when compared to 
those with at least 36 months of infertility, couples with less than 36 months of 
infertility were achieving live birth faster (HR = 1.68, 95% CI: 1.14 – 2.48) [57]. 
Another study found that among couples with unexplained infertility receiving 
ART treatments, the duration of infertility was significantly different between 
couples who achieved pregnancy and did not achieve pregnancy, with mean 
durations of 20.2 months and 24.6 months, respectively (p-value < 0.001) [9]. 
Likewise, several other studies have shown that shorter durations of infertility are 
significantly associated with higher likelihoods of conception and delivery [8, 55, 
58, 59, 61], with one study having duration of infertility as the only significant 
predictor of spontaneous conception among women receiving IVF [55]. 
 
Female age  
 The age of the female is one of the strongest predictors of pregnancy. 
This is largely due to decline of function of the female reproductive system with 
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increasing age. At the age of puberty, women embody 300,000 to 500,000 
oocytes; at 37 years of age, only 25,000 oocytes; and roughly 1,000 at the age of 
51 years [96]. The levels of FSH and AMH also change throughout a woman’s 
life; gradually, FSH increases and AMH decreases with increased age [96]. As 
mentioned in a separate section, increased FSH levels are associated with lower 
pregnancy rates, as well as lower AMH levels [80]. The combination of fewer 
oocytes, increased FSH levels, and decreased AMH levels results in slow but 
significant decline of fecundity in women beginning around the age of 32 years, 
and decreases rapidly after the age of 37 years [96]. Several studies have found 
negative associations between female age and the likelihood of conception, 
either spontaneous or while receiving ART [3, 4, 6, 8, 9, 56, 57, 59].  
 One retrospective study assessing subsequent spontaneous conceptions 
after successful or unsuccessful IVF/ICSI treatments found a negative 
association with female age and the likelihood of conception [8]. Among those 
with prior successful IVF/ICSI treatments, when compared to women less than 
30 years of age, women between the ages of 35 and 39 (OR = 0.30, 95% CI: 
0.18 – 0.49) and women 40 or older (OR = 0.25, 95% CI 0.07 – 0.86) had 
significantly less odds of spontaneously conceiving. Similarly, among women 
with prior unsuccessful IVF/ICSI treatments, compared to those less than 30 
years of age, women between 30 and 34 (OR = 0.50, 95% CI: 0.31 – 0.82), 
between 35 and 39 (OR = 0.24, 95% CI: 0.14 – 0.43), and 40 or older (OR = 
0.18, 95% CI: 0.09 – 0.38) had significantly less odds of spontaneously 
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conceiving. Between both groups, a negative linear trend is present between 
female age and likelihood of spontaneous conception.  
 Similarly, a study of infertile couples that have remained untreated, by 
utilizing proportional hazards analysis, found that women less than 30 years old 
were 50% more likely to conceive than women 30 years old or older (HR = 1.50, 
95% CI: 1.05 – 2.16) [57]. A longitudinal study of couples with unexplained 
infertility found that women who achieved spontaneous conception were 
significantly younger than women who were not able to spontaneously conceive, 
with mean ages of 31.3 and 34.1, respectively  (p=<0.001) [9].  
The clinical and epidemiological evidence shows that increased female 
age results in decreased fecundity and decreased likelihood of conception. In 
models of likelihood of conception, female age should always be controlled for, 
and it is unsurprising when female age is significantly and negatively associated 
with likelihood of conception. 
 
Infertility diagnosis  
 Between varying studies, certain infertility diagnoses may be more 
associated with the likelihood of conception than others. Several studies found 
that different infertility diagnoses have significantly different associations with 
spontaneous conception among varying populations of infertile couples, including 
a study [2] of infertile couples after IVF treatments, regardless of their success 
(p-value – 0.024), and another study [3] of infertile couples after only successful 
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IVF treatments (p-value = 0.0535). When studies do show significant differences 
in infertility diagnoses and conception or live birth rates, they do not consistently 
result in the same diagnoses being associated with conception. However, 
unexplained infertility seems to be the best diagnosis for likelihood of pregnancy. 
 
Unexplained  
Unexplained infertility seems to be the best diagnosis for likelihood of 
conception. A retrospective internet survey study found that among women who 
had discontinued IVF/ICSI, those with unexplained infertility were 2.82 times 
more likely to spontaneously conceive than those with tubal damage (p = 0.005) 
[7]. Another study found that among infertile couples who remained untreated by 
ART, those with unexplained infertility were more than twice as likely to 
spontaneously conceive than those with tubal infertility (HR = 2.64, 95% CI: 1.75 
– 3.98) [59]. Further, one study found that couples with prior unsuccessful IVF 
treatments and unexplained infertility are nearly 3 times higher odds of 
conception than couples with male factor infertility and prior unsuccessful IVF 
(OR = 2.98, 95% CI: 1.60 – 5.53) [8]. Several studies, with varying populations, 
report that unexplained infertility is the infertility diagnosis with the highest 
likelihood of conception or live birth [3, 5, 57, 59]. 
 
Male Factor 
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In a study among untreated infertile couples, those with an infertility 
diagnoses of male defect were having live births at less than half the rate of 
those without a male defect diagnosis (HR = 0.47, 95% CI: 0.27 – 0.81) [57]. 
Interestingly, another study among untreated infertile couples found that couples 
with male factor infertility were spontaneously conceiving 57% faster than those 
with tubal factor infertility (HR = 1.57, 95% CI: 1.06 – 2.32) [59]. It should be 
noted that in these analyses, one compared male factor infertility to no male 
factor infertility, whereas the other compared male factor infertility to tubal factor 
infertility, which could explain the conflicting results, even with both studies 
among untreated infertile couples.  
 
Endometriosis 
Very little studies have found significant associations between 
endometriosis and the likelihood of conception. One follow-up study found that, 
among couples with prior live births from IVF/ICSI, those with an infertility 
diagnosis of endometriosis had the highest rate of subsequent spontaneous 
conception (28.3% of diagnosed conceived) [3]. However, another study found 
that having endometriosis significantly lowered the time to spontaneous 
conception (HR = 0.39, 95% CI: 0.18 – 0.85) among untreated infertile couples 
when compared to couples without an endometriosis diagnosis [57]. Again, the 
specific comparisons in each of these studies could be the reason behind the 
conflicting results.  
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Tubal Factor 
Few studies have found significant associations between tubal factor 
infertility and the likelihood of spontaneous conception or live birth, but those that 
do find significant associations only report negative associations. One study 
found that among untreated infertile couples, those with a tubal defect were 
spontaneously conceiving in half the time of those without a tubal defect (HR = 
0.50, 95% CI: 0.40 – 0.63) [57]. Similarly, another study of untreated infertile 
couples found that a tubal factor infertility diagnosis significantly decreased the 
likelihood of live birth after spontaneous conception (Relative likelihood = 0.14, 
95% CI: 0.06 – 0.33) when compared to those with no tubal diagnosis [58]. 
Further, another study found that among couples who had discontinued IVF 
treatments at least 3 years prior, those with tubal factor infertility were 7 times 
less likely to spontaneously conceive (RR = 0.13, 95% CI: 0.03 – 0.52) when 
compared to those with a diagnosis of “other” (mostly ovulatory factors), with only 
6.3% of those with tubal factor infertility achieving conception [2].  
 
Ovulation Factor 
 Among the literature, ovulation factor infertility seems to be negatively 
associated with spontaneous conception. An internet survey study among 
women who had discontinued IVF or ICSI treatments found that those women 
with ovulation factor infertility had 2.58 times the odds (95% CI: 1.02 – 6.53) to 
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conceive spontaneously when compared to the referent group of tubal infertility 
[7]. A study of untreated infertile couples found similar findings, with couples 
having a diagnosis of ovulation defect decreasing the likelihood of live birth after 
spontaneous conception (Relative likelihood = 0.35, 95% CI: 0.21 – 0.58) when 
compared to those with no ovulation defect [58]. Interestingly, however, one 
study reports that having an infertility diagnosis of “other” (which the authors say 
were mostly ovulatory diagnoses) had the highest rates of spontaneous 
conception among couples who had discontinued IVF treatments at least 3 years 
ago; 46.2% of women with the “other” diagnosis spontaneously conceived [2]. It 
is unknown, however, just how much of this group, containing only 13 couples, 
actually had an ovulatory factor diagnosis.  
 
PCOS 
 Infertility diagnoses of PCOS are, to the best of my knowledge, not used in 
current models of conception among infertile couples; it is assumed that if PCOS 
diagnoses are included in these analyses, that it is part of an ovulatory factor 
diagnosis. However, the current thesis will include PCOS as its own diagnosis, 
as 39 (22.6%) participants have a clinical PCOS diagnosis, and 48 (27.9%) are 
self-reporting PCOS. As mentioned in prior sections, PCOS is a Group II ovarian 
factor infertility diagnosis, and accounts for 70% of infertility due to anovulation 
[47]. An excess of free androgen and a decrease FSH contribute to the formation 
of several pre-ovulatory follicles on the ovaries [47]. PCOS is associated with 
obesity, as obesity-related insulin resistance can lower the amounts of FSH and 
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increase the amounts of androgens [64]. Women with PCOS are twice as likely 
to be overweight than women without PCOS [66]. 
 
Male age 
Few studies utilize the male partner’s age as predictors of likelihood of 
conception, and most of those that do find no association [8, 56, 57]. However, 
one longitudinal cohort study found that among 437 couples with unexplained 
infertility, those women who achieved pregnancy had partners of younger age 
than those women who did not conceive, with mean male ages of 33.3 and 35.9, 
respectively (p-value < 0.001) [9].  
 
Sperm Volume and Sperm Motility 
 In a fairly recent follow-up study of women who had a prior successful live 
birth as a result of IVF, those with partners of whom had higher concentrations of 
sperm volume were more likely to conceive (p-value < 0.01) [5]. Likewise, the 
women whose partners had higher sperm motility percentages were more likely 
to conceive (p-value < 0.001). Another study of couples who had discontinued 
ART, found that women who did not conceive were significantly more likely to 
have partners with non-normal semen analyses than those women who did 
conceive spontaneously (p-value = 0.03) [56]. These results could be interpreted 
as infertility diagnosis; meaning that those couples with male factor infertility due 
to non-normal sperm motility and volume are less likely to conceive 
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spontaneously than those couples without male factor infertility, which has been 
the result of prior mentioned papers [3, 57]. 
 
Number of ART Treatments  
One retrospective study, of which utilized logistic regression, found that 
women who had prior successful IVF treatments, having 2 to 4 treatment 
attempts significantly decreased the odds of a subsequent live birth (OR 
compared to 1 attempt = 0.65, 95% CI: 0.47 – 0.89) [8]. Likewise, having 5 to 14 
attempts significantly decreased the odds of subsequent spontaneous live birth 
(OR compared to 1 attempt = 0.44, 95% CI: 0.23 – 0.82). Similarly, among 
women who had prior unsuccessful IVF treatments, having 2 to 4 IVF attempts 
(OR compared to 1 attempt: 0.39, 95% CI: 0.26 – 0.60) or 5 to 14 IVF attempts 
(OR compared to 1 attempt = 0.15, 95% CI: 0.07 – 0.32) significantly decreased 
the odds of subsequent spontaneous live birth. Among both the successful and 
unsuccessful IVF women, those who had only one attempt were more likely to 
have a live birth as a result of spontaneous conception. These results seem to 
suggest that those women of whom are fertile enough to conceive 
spontaneously, do not require treatments; whereas those who are not fertile 
enough to achieve spontaneous conception, would require several attempts.  
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D. METHODS 
 
LOUSSI Study Recruitment and Baseline Data Collection 
 For this thesis, data were used from the Louisville Tobacco Smoke 
Exposure, Genetic Susceptibility, & Infertility Study (LOUSSI) (NICHD R15-
HS087911). The original purpose of the LOUSSI Study was to assess the effects 
of smoking habits and NAT2 genotype on fertility. Participants were recruited at 
the University of Louisville Reproductive Endocrinology and Infertility (REI) clinic 
between September 2016 and June 2018 (N=264).  A physician explained the 
purpose of the study to the patients and if the patient expressed interest, a 
LOUSSI team member explained the study in more detail. If the patient agreed, 
informed consent was obtained (IRB number: 16.0063) and a $25 incentive was 
extended. Exclusion criteria included being younger than 21 years of age, having 
an ongoing pregnancy, inability to communicate in English, and having no 
chance of achieving pregnancy i.e. hysterectomy, AMH levels nonexistent. Most 
participants gave a urine sample, which was used to assay cotinine levels and 
NAT2 genotype.  All participants answered a smoking questionnaire to assess 
current and past exposure to tobacco smoke and other nicotine products.  
Demographic information and medical history (e.g., AMH levels, infertility 
diagnoses, STI history, ART treatments, conception data) was extracted from 
medical records. Baseline variables included age, BMI, race, blood pressure, age 
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at menarche, smoking status/amount, alcohol use/amount, and drug use. All 
other variables were collected from patient history forms or medical records. 
Permission to recontact participants began at participant #100.  
 
Follow-Up Data Collection 
 Participants that gave permission for recontact were followed up with an 
email at least 6 months after enrolling into the LOUSSI Study. If not reached by 
email, participants were contacted by phone.  For working phone numbers, up to 
3 attempts were made to contact each participant by phone. Still, if contact was 
not made, they were mailed a paper questionnaire with a pre-addressed and pre-
stamped return envelope. For those participants who were never recontacted, 
and for those of whom were never asked to be recontacted, pregnancy data was 
extracted from medical records.  
 Conception was defined as having achieved a clinical pregnancy by a 
positive pregnancy test, regardless of its outcome. The conception date was 
defined as the month after the last menstrual period as reported by the 
participants, or nine months before the due date as reported by the participant. 
From the medical records, the conception date was defined as either the 
conception date as recorded by the physician, or the month after the last 
menstrual period as recorded by the physician. ART treatments after initial 
enrollment were also extracted from medical records.   
 
Descriptive Statistics 
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 All statistics were determined by SAS Software (9.4). Three sub-samples 
were included for analysis: the total population, and the total population stratified 
by ART status (ever versus never). Descriptive statistics were analyzed in four 
ways, by which all variables were examined for an association with pregnancy 
(any versus none) in each of the three sub-samples, as well for an association 
with STI history (any versus none). Chi-square and Fisher’s Exact test were 
reported; Fisher’s Exact test was reported when the expected value was less 
than 5 for at least 25% of the cells. Significant associations were defined by a 
Chi-square or Fisher’s Exact p-value of 0.05 or less.  
 
Etiologic Logistic Regression Modeling 
Treatment of variables for modeling are shown in Table 2.   
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Table 2: Variable Definitions and Treatment in Modeling 





*BMI < 30 
BMI >= 30 





*Low: Systolic BP < 120 and Diastolic BP < 80 
Medium: Systolic BP between 120-129 and Diastolic BP < 80 
High: Systolic BP >= 130 and Diastolic BP < 89 
Alcohol Use Yes/*No 
Smoker 
Smoker = cotinine level >= 100 or self-report of smoking 
*Non-Smoker = cotinine level < 100 and no self-report of smoking 
ln(AMH) Continuous 
Tubal Diagnosis Yes/*No 
Uterine Diagnosis Yes/*No 
Ovarian Diagnosis Yes/*No 
Male Diagnosis Yes/*No 
PCOS Diagnosis Yes/*No 
History of STI Yes/*No 
History of HPV Yes/*No 
History of Chlamydia Yes/*No 
ART during Cycle Yes/*No 
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To determine the effects of STI history on the likelihood of conception, 
logistic regression models were performed on the three sub-samples of the 
current population: 1) on the entire 170 women in the follow-up population; 2) on 
women who did not receive any ART treatment during the entire follow up; and 3) 
on women who received ART treatment at least once during the follow up. The 
dichotomous outcome for all models was pregnancy, with history of any STI 
being the main exposure of interest. Variables to be initially included in each 
model were chosen by a Chi-square or Fisher’s Exact test p-value <= 0.2 in the 
bivariable analysis with either STI history or pregnancy in the relevant population. 
For example, for a variable to be included in the model of women with no ART 
treatments, the variable had a p-value <= 0.2 when compared to STI history or 
when compared to pregnancies among the sub-sample with no ART treatments.  
Because of the overwhelming evidence in the literature for the effects of older 
age and obesity on reduced fertility, age and obesity were included in all models, 
regardless of their descriptive statistic p-value.  
Continuous variables were assessed for a dose-response by examining 
multiple categories’ effects on the outcome. If a dose-response was found, then 
the variable was treated continuously. If a threshold effect was detected, similar 
categories were combined. Two-way interaction terms were tested in each model 
by including product terms. However, in all three models, all interactions were 
statistically non-significant, and therefore no interaction terms were kept in any 
model.  
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A data-based method for assessing confounding was used. Confounders 
were defined as those variables that changed the OR for STI by more than 10% 
when removed from the model. Variables that were not confounders were 
examined for their effect on the precision of the effect of STI (i.e., the width of the 
95% confidence interval for STI).  If a variable removed from the model changed 
the OR of STI on pregnancy by less than 10%, but increased precision, the 
variable was retained.  Age and obesity were forced into the model due to the 
abundance of evidence of a strong association with fertility. Multicollinearity was 
tested several times throughout each modeling process by examining the 
variance decomposition proportions for all variables.  Lastly, a Hosmer-
Lemeshow test was conducted on each of the final models to determine 
goodness of fit. Models were determined to be of good fit when the Hosmer-
Lemeshow test p-value was greater than 0.05, of which all final models exhibited.  
AMH was log-transformed (ln(AMH)) due to the skewed distribution of the 
variable.   
Additionally, the variable for a uterine infertility diagnosis was not included 
in the testing of all models, as only nine participants had a uterine diagnosis. 
Likewise, the unknown diagnosis variable was excluded from the models of those 
who ever received ART, as only six participants in this sub-sample had this 
specific diagnosis.  
 
Predictive Logistic Regression Modeling 
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To determine which factors were associated with the odds of pregnancy, 
predictive logistic regression models were performed, with pregnancy being the 
dichotomous outcome. Similar to the etiologic regression models, three predictive 
regression models were performed on the three sub-samples of the study. All 
variables were tested to determine their inclusion in the model, as well as several 
interaction terms. However, variables with a p-value of 0.2 or less were chosen to 
be initially included in the model, and after a stepwise analysis, those variables 
with a p-value of 0.2 or less were retained in the final model. Based on the 
evidence of a strong association with fertility, age and obesity were forced into 
each model, regardless of their respective p-values. Finally, a Hosmer-
Lemeshow goodness of fit test was performed on all final models, and models 
were determined to be of good fit if the test p-value was greater than 0.05. 
Across all logistic regression analyses, significance is defined by a p-value of 
0.05 or less. 
It should also be noted that in two of the sub-samples, AMH levels were 
missing for 20 participants; for these two sub-samples, models were first tested 
with the AMH variable included to determine if AMH would be selected for the 
final model. Neither of the two models included AMH, so a second test was 
performed excluding the AMH variable, which resulted in final predictive models 
with larger sample sizes. For the third sample, those who ever received ART, all 
AMH values were present.  
 
Survival Analyses 
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Follow-up data was used to determine the time to pregnancy.  The start 
time was defined as the enrollment month of the participant – time 0, whereas 
the end time was either 1) the last medical record entry, 2) the conception date, 
3) the last contact with the participant, or 4) the last month that the participant 
was actively trying to achieve pregnancy. ART was included as a time-varying 
covariate.  
 Six separate survival analyses were conducted, respective to the six 
logistic regression performed: etiologic models with history of STI as the main 
exposure of interest among the three sub-samples, as well as predictive models 
among the three sub-samples. Variables to be included for testing in each 
survival analysis were those variables that were included in the final models of 
the respective logistic regressions. Across all survival analyses, significance is 
defined by a p-value of 0.05 or less. 
 The Proportional Hazards Assumption was assessed for each variable 
included in each of the six models. For those variables that violated the 
assumption, either by a correlation between Schoenfeld residual and time p-
value of less than 0.05 or by examining their log-negative log curves, models 
were adjusted for the violating variable by either stratification or inclusion of an 
interaction term with time. 
 Time-varying data was used with ART per cycle (yes/no) being the time-
varying covariate. In the two models produced for the sub-sample among those 
with no ART, the time-varying ART variable was not included; none of the women 
had ever received ART treatments, therefore none of the women had any value 
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for ART other than 0. However, in the models produced for the entire population 
and for the sub-sample of women who ever received ART, the time-varying ART 
variable was included, and hazard ratio estimates could be produced.  
 Among the four models in which the time-varying ART variable was 
included, determination of whether the ART variable met the Proportional 
Hazards assumption was tested by the production of an extended Cox model 
adjusting for all other covariates; if the ART*time variable had a significant p-
value, it was considered to be significantly associated with time, and the final 
model was stratified by ART.   
 Kaplan-Meier survival curves were produced for all variables present in 
each model. Additionally, for each of the three etiologic models, adjusted survival 
curves were created for STI, controlling for all other variables in each model. 
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E. RESULTS 
 
Of the 264 participants in the entire LOUSSI cohort, follow-up data was 
successfully collected for 170 (64.4%), either by extraction of medical records 
from a follow-up visit at the Fertility Clinic, and/or by direct recontact for those of 
whom permission was obtained (requested of participants 100-264) (Figure 1).  6 
participants from the second group (numbers 100-264) declined to be 
recontacted; therefore, we obtained permission to recontact 157 people.
 
Of these 170 women, 82 (48.2%) never received an ART treatment after 
enrolling in the LOUSSI Study, and 88 (51.8%) received at least one cycle of 
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ART treatment (Figure 2). There were 76 (44.7%) women who achieved at least 
one pregnancy since enrollment. Among those women who never received ART, 
32 (39.0%) achieved a spontaneous pregnancy. Among those women who ever 
received ART, 44 (50%) achieved a pregnancy, of which 35 (79.5%) were 
through the means of ART, and 9 (20.5%) were spontaneous conceptions.   
 
 
Descriptive Statistics by Conception Status Among all Sub-Samples 
Table 3 shows the characteristics of all the women (N=170) included in 
this study stratified by pregnancy status (any vs. none). Those women who did 
achieve pregnancy were younger and less likely to be obese. However, these 
differences were not statistically significant. Women who achieved a pregnancy 
had lower cotinine levels (P-value = 0.019), had higher AMH levels (P-value = 
0.004), and were more likely to have an ovarian (P-value = 0.024) or a PCOS (P-
value = 0.041) infertility diagnosis than women who did not conceive. 
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Table 3: Characteristics Among Entire Follow-Up 
Stratified by Conception Status (N=170) 















   
Age   0.398    
<=27 24 (31.58) 20 (21.28)     
28 - 32 19 (25.00) 22 (23.40)     
33 - 37 19 (25.00) 30 (31.91)     
>37 14 (18.42) 22 (23.40)     
BMI   0.219    
<18.5 1 (1.32) 3 (3.19)     
18.5 - 24.9 20 (26.32) 18 (19.15)     
25.0 - 29.9 26 (34.21) 24 (25.53)     
>=30 29 (38.16) 49 (52.12)     
Race   0.091    
White 46 (60.53) 50 (53.19)     
Black 14 (18.42) 32 (34.04)     
Asian 5 (6.58) 6 (6.38)     
Native American 1 (1.32) 0 (0.00)     
Middle Eastern 2 (2.63) 0 (0.00)     
Hispanic 8 (10.53) 6 (6.38)     
Diastolic BP   0.056    
<80 45 (59.21) 53 (56.38)     
80-89 25 (32.89) 22 (23.40)     
>=90 6 (7.89) 19 (20.21)     
Systolic BP 
  
0.898    
< 120 33 (43.42) 38 (40.43)     
120-129 19 (25.00) 24 (25.53)     
130-139  17 (22.37) 20 (21.28)     
>= 140 7 (9.21) 12 (12.77)     
Alcohol 
  
0.813    
Yes 35 (46.05) 45 (47.87)     




0.581    
0 46 (60.53) 56 (59.57)     
0-1  12 (15.79) 20 (21.28)     




0.133    
<=1 39 (51.32) 59 (62.77)     
>=2 37 (48.68) 35 (37.23)     




0.224    
Yes 10 (13.16) 19 (20.21)     
No 66 (86.84) 75 (79.79)     
Packs per Day   0.310    
0 66 (86.84) 75 (79.79)     
<1 5 (6.58) 13 (13.83)     




0.019    
<1 32 (42.11) 47 (50.00)     
1-10 24 (31.58) 13 (13.83)     




0.004    
<0.3 6 (8.57) 11 (13.75)     
0.3-0.6 0 (0.00) 7 (8.75)     
0.7-0.9 6 (8.57) 0 (0.00)     
1-2.9 25 (35.71) 30 (37.50)     





0.844    
<12 32 (42.11) 42 (44.68)     
13-24 17 (22.37) 16 (17.02)     
25-48 9 (11.84) 13 (13.83)     
>= 48 18 (23.68) 23 (24.47)     
Age at Menarche 
(years) 
  
0.872    
7-10.9 9 (11.84) 13 (14.77)     
11-12.9 26 (34.21) 32 (36.36)     
13-14 21 (27.63) 20 (22.73)     
>14 20 (26.32) 23 (26.14)     
ART   0.150    
Yes 44 (57.89) 44 (46.81)     
No 32 (42.11) 50 (53.19)     
Illicit Drug Use   0.382    
Yes 1 (1.33) 4 (4.30)     




0.458    
Yes 12 (15.79) 19 (20.21)     




0.059    
Yes 5 (6.58) 15 (15.96)     
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0.302    
Yes 6 (7.89) 3 (3.19)     




0.024    
Yes 21 (27.63) 13 (13.83)     




0.148    
Yes 16 (21.05) 12 (12.77)     
No 60 (78.95) 82 (87.23)     
PCOS Diagnosis   0.041    
Yes 23 (30.26) 16 (17.02)     
No 53 (69.74) 78 (82.98)     
Other Diagnosis   1.000    
Yes 1 (1.32) 2 (2.13)     




0.230    
Yes 15 (19.74) 26 (27.66)     
No 61 (80.26) 68 (72.34)     
History of STI 
  
0.902    
Yes 29 (38.16) 35 (37.23)     




0.243    
Yes 13 (17.11) 23 (24.47)     




0.132    
Yes 1 (1.32) 6 (6.38)     
No 75 (98.68) 88 (93.62)     
History of HPV 
  
0.147    
Yes 14 (18.42) 10 (10.64)     




0.462    
Yes 2 (2.63) 5 (5.32)     
No 74 (97.37) 89 (94.68)     
 
Characteristics among women who never received ART treatments 
(N=82) are shown in Table 4. Among this sub-sample, women who achieved a 
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pregnancy were younger and less obese, but again, not significantly. Women 
who did not achieve pregnancy had higher diastolic blood pressure. Those who 
achieved pregnancy were comparable to those who did not achieve pregnancy in 
all comparisons.  
Table 4: Characteristics Among Those with No ART 
















Age   0.428 
<=27 14 (43.75) 14 (28.00)  
28 - 32 8 (25.00) 14 (28.00)  
33 - 37 5 (15.63) 14 (28.00)  
>37 5 (15.63) 8 (16.00)  
BMI   0.150 
<18.5 0 (0.00) 3 (6.00)  
18.5 - 24.9 9 (28.13) 13 (26.00)  
25.0 - 29.9 11 (34.38) 8 (16.00)  
>=30 12 (52.00) 26 (52.00)  
Race   0.359 
White 14 (43.75) 25 (50.00)  
Black 9 (28.13) 18 (36.00)  
Asian 4 (12.50) 4 (8.00)  
Native American 0 (0.00) 0 (0.00)  
Middle Eastern 2 (6.25) 0 (0.00)  
Hispanic 3 (9.38) 3 (6.00)  
Diastolic BP   0.058 
<80 21 (65.63) 28 (56.00)  
80-89 10 (31.25) 11 (22.00)  
>=90 1 (3.13) 11 (22.00)  
Systolic BP   0.799 
< 120  16 (50.00) 21 (42.00)  
120-129 8 (25.00) 14 (28.00)  
130-139 6 (18.75)  9 (18.00)  
>= 140 2 (6.25) 6 (12.00)  
Alcohol   0.133 
Yes 10 (31.25) 24 (48.00)  
No 22 (68.75) 26 (52.00)  
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Alcoholic 
Drinks per 
Week   0.305 
0 25 (78.13) 31 (62.00)  
0-1  3 (9.38) 9 (18.00)  
>1 4 (12.50) 10 (20.00)  
Caffeine Drinks 
per Day 
  0.902 
<=1 19 (59.38) 29 (58.00)  
>=2 13 (40.63) 21 (42.00)  
Self-Report 
Smoker 
  0.258 
Yes 7 (21.88) 16 (32.00)  
No 25 (78.13) 34 (68.00)  
Packs per Day   0.618 
0 25 (78.13) 34 (68.00)  
<1 5 (15.63) 10 (20.00)  
>=1 2 (6.25) 6 (12.00)  
Cotinine Level 
(ng/mL) 
  0.480 
<1 12 (37.50) 20 (40.00)  
1-10 7 (21.88) 6 (12.00)  
>10 13 (40.63) 24 (48.00)  
AMH Level 
(ng/mL)   0.514 
<0.3 4 (15.38) 6 (16.67)  
0.3-0.6 0 (0.00) 0 (0.00)  
0.7-0.9 2 (7.69) 0 (0.00)  
1-2.9 9 (34.62) 14 (38.89)  
>=3 11 (42.31) 16 (44.44)  
Duration of 
Infertility 
(months)   0.268 
<12 14 (43.75) 21 (42.00)  
13-24 9 (28.13) 10 (20.00)  
25-48 6 (18.75) 6 (12.00)  
>= 48 3 (9.38) 13 (26.00)  
Age at 
Menarche 
(years)   0.968 
7-10.9 6 (18.75) 8 (17.02)  
11-12.9 11 (34.38) 16 (34.04)  
13-14 7 (21.88) 9 (19.15)  
>14 8 (25.00) 14 (29.79)  
Illicit Drug Use   0.644 
Yes 1 (3.23) 4 (8.16)  
No 30 (96.77) 45 (91.84)  
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Unexplained 
Diagnosis 
  0.396 
Yes 1 (3.13) 5 (10.00)  
No 31 (96.88) 45(90.00)  
 Tubal Factor 
Diagnosis 
  0.114 
Yes 2 (6.25) 10 (20.00)  
No 30 (93.75) 40 (80.00)  
Uterine 
Diagnosis 
  1.000 
Yes 1 (3.13) 2 (4.00)  
No 31 (96.88) 48 (96.00)  
Ovarian 
Diagnosis 
  0.280 
Yes 9 (28.13) 9 (18.00)  
No 23 (71.88) 41 (82.00)  
Male Factor 
Diagnosis 
  0.144 
Yes 6 (18.75) 3 (6.00)  
No 26 (81.25) 47 (94.00)  
PCOS 
Diagnosis   0.316 
Yes 8 (25.00 8 (16.00)  
No 24 (75.00) 42 (84.00)  
Other 
Diagnosis   1.000 
Yes 0 (0.00) 1 (2.00)  
No 32 (100) 49 (98.00)  
Unknown 
Diagnosis 
  0.876 
Yes 14 (43.75) 21 (42.00)  
No  18 (56.25) 29 (58.00)  
History of STI   0.891 
Yes 12 (37.50) 18 (36.00)  
No 20 (62.50) 32 (64.00)  
History of 
Chlamydia   0.723 
Yes 6 (18.75) 11 (22.00)  
No 26 (81.25) 39 (78.00)  
History of 
Gonorrhea   1.000 
Yes 1 (3.13) 3 (6.00)  
No 31 (96.88) 47 (94.00)  
History of HPV   0.674 
Yes 3 (9.38) 3 (6.12)  
No 29 (90.63) 47 (94.00)  
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History of 
Herpes   0.396 
Yes 1 (3.13) 5 (10.00)  
No 31 (96.88) 45 (90.00)  
 
Table 5 displays the characteristics among women who ever received 
ART (N=88) after enrollment. Similar to the other sub-samples, those who 
achieved pregnancy were generally younger and less obese, but not significantly. 
Those who did become pregnant had significantly higher AMH levels (P-value = 
0.005) and were significantly more likely to have an ovarian infertility diagnosis 
(P-value = 0.027).  
Table 5: Characteristics Among Those with ART 
















Age   0.441 
<=27 10 (22.73) 6 (13.64)  
28 - 32 11 (25.00) 8 (18.18)  
33 - 37 14 (31.82) 16 (36.36)  
>37 9 (20.45) 14 (31.82)  
BMI   0.242 
<18.5 1 (2.27) 0 (0.00)  
18.5 - 24.9 11 (25.00) 5 (11.36)  
25.0 - 29.9 15 (34.09) 16 (36.36)  
>=30 17 (52.27) 23 (52.27)  
Race   0.090 
White 32 (72.73) 25 (56.82)  
Black 5 (11.36) 14 (31.82)  
Asian 1 (2.27) 2 (4.55)  
Native American 1 (2.27) 0 (0.00)  
Middle Eastern 0 (0.00) 0 (0.00)  
Hispanic 5 (11.36) 3 (6.82)  
Diastolic BP    0.515 
<80 24 (54.55) 25 (56.82)  
80-89 15 (34.09) 11 (25.00)  
>=90 5 (11.36) 8 (18.18)  




< 120 17 (38.64) 17 (38.64)  
120-129  11 (25.00) 10 (22.73)  
130-139 11 (25.00) 11 (25.00)  




Yes 25 (56.82) 21 (47.73)  





0 21 (47.73) 25 (56.82)  
0-1  9 (20.45) 11 (25.00)  





<=1 20 (45.45) 30 (68.18)  





Yes 3 (6.82) 3 (6.82)  
No 41 (93.18) 41 (93.18)  
Packs per Day   0.058 
0 41 (93.18) 41 (93.18)  
<1 0 (0.00) 3 (6.82)  





<1 20 (45.45) 27 (61.36)  
1-10 17 (38.64) 7 (15.92)  





<0.3 2 (4.55) 5 (11.36)  
0.3-0.6 0 (0.00) 7 (15.91)  
0.7-0.9 4 (9.09) 0 (0.00)  
1-2.9 16 (36.36) 16 (36.36)  






<12 18 (40.91) 21 (47.73)  
13-24 8 (18.18) 6 (13.64)  
25-48 3 (6.82) 7 (15.91)  
>= 48 15 (34.09) 10 (22.73)  
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7-10.9 3 (6.82) 5 (12.20)  
11-12.9 15 (34.09) 16 (39.02)  
13-14 14 (31.82) 11 (26.83)  
>14 12 (27.27) 9 (21.95)  
Illicit Drug Use   - 
Yes 0 (0.00) 0 (0.00)  





Yes 11 (25.00) 14 (31.82)  
No 33 (75.00) 30 (68.18)  




Yes 3 (6.82) 5 (11.36)  





Yes 5 (11.36) 1 (2.27)  





Yes 12 (27.27) 4 (9.09)  





Yes 10 (22.73) 9 (20.45)  
No 34 (77.27) 35 (79.55)  
PCOS Diagnosis   0.089 
Yes 15 (34.09) 8 (18.18)  
No 29 (65.91) 36 (81.82)  
Other Diagnosis   1.000 
Yes 1 (2.33) 1 (2.22)  





Yes 1 (2.27) 5 (11.36)  
No 43 (97.73) 39 (88.64)  
History of STI 
  
1.000 
Yes 17 (39.53) 17 (39.53)  





Yes 7 (15.91) 12 (27.27)  
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Yes 0 (0.00) 3 (6.82)  
No 44 (100) 41 (93.18)  
History of HPV 
  
0.291 
Yes 11 (25.00) 7 (15.91)  





Yes 1 (2.27) 0 (0.00)  
No 43 (97.73) 44 (100)  
 
Descriptive Statistics by STI Status 
Among the total sample of 170 women, 64 (37.6%) had a history of any 
STI, whereas 106 (62.4%) had no history of any STI. The 64 with a history of any 
STI consisted of 36 chlamydia infections, 7 gonorrhea infections, 24 HPV 
infections, and 7 herpes infections, totaling 74 past STI infections (some 
participants had a history of more than one STI). Among these 64 women, 29 
(45.3%) achieved a pregnancy, 12 (41.4%) of which were women who never 
received ART and 17 (58.6%) of which had received ART.  
In Table 6, characteristics of the entire sample stratified by STI history is 
shown. Those with a history of STI were more likely to be non-white (P-value = 
0.013) and consume alcohol (P-value = 0.002). Additionally, those with a history 
of STI were more likely to have a tubal infertility diagnosis (P-value = 0.028), but 
less likely to have an ovarian infertility diagnosis (P-value = 0.022).  
 
Table 6: Characteristics Among Entire Follow-Up Stratified 
by History of STI (N=170) 














    
Age   0.413     
<=27 12 (18.75) 32 (30.19)      
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28 - 32 16 (25.00) 25 (23.58)      
33 - 37 21 (32.81) 28 (26.42)      
>37 15 (23.44) 21 (19.81)      
BMI   0.969     
<18.5 1 (1.56) 3 (2.83)      
18.5 - 24.9 14 (21.88) 24 (22.64)      
25.0 - 29.9 18 (28.13) 32 (30.19)      
>=30 31 (48.44) 47 (44.34)      
Race   0.013     
White 31 (48.44) 65 (61.32)      
Black 27 (42.19) 19 (17.92)      
Asian 3 (4.69) 8 (7.55)      
Native American 0 (0.00) 1 (0.94)      
Middle Eastern 0 (0.00) 2 (1.89)      
Hispanic 3 (4.69) 11 (10.38)      
Diastolic BP   0.897     
<80 36 (56.25) 62 (58.49)      
80-89 19 (29.69) 28 (26.42)      
>=90 9 (14.06) 16 (15.09)      
Systolic BP 
  0.750     
< 120 26 (40.63) 45 (42.45) 
     
120-129 19 (29.69) 24 (22.64) 
     
130-139 13 (20.31) 24 (22.64) 
     
>= 140 6 (9.38) 13 (12.26) 
     
Alcohol 
  0.002     
Yes 40 (62.50) 40 (37.74) 
     
No 24 (37.50) 66 (62.26) 
     
Alcoholic Drinks 
per Week 
  0.055     
0 31 (48.44) 71 (66.98)      
0-1  15 (23.44) 17 (16.04)      
>1 18 (28.13) 18 (16.98)      
Caffeine Drinks 
per Day 
  0.775     
<=1 36 (56.25) 62 (58.49)      
>=2 28 (43.75) 44 (41.51)      
Self-Report 
Smoker 
  0.086     
Yes 15 (23.44) 14 (13.21)      
No 49 (76.56) 92 (86.79)      
Packs per Day   0.151     
0 49 (76.56) 92 (86.79)      
<1 8 (12.50) 10 (.43)      
>=1 7 (10.94) 4 (3.77)      
Cotinine Level 
(ng/mL) 
  0.524     
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<1 31 (48.44) 48 (45.28)      
1-10 11 (17.19) 26 (24.53)      
>10 22 (34.38) 32 (30.19)      
AMH Level 
(ng/mL) 
  0.228     
<0.3 3 (5.36) 14 (14.89)      
0.3-0.6 2 (3.57) 5 (5.32)      
0.7-0.9 4 (7.14) 2 (2.13)      
1-2.9 23 (41.07) 32 (34.04)      




  0.381     
<12 30 (46.88) 44 (41.52) 
     
13-24 10 (15.63) 23 (21.70) 
     
25-48 11 (17.19) 11 (10.38) 
     
>= 48 12 (20.31) 28 (26.42) 
     
Age at Menarche 
(years) 
  0.475     
7-10.9 6 (9.52) 16 (15.84)      
11-12.9 26 (41.27) 32 (31.68)      
13-14 14 (22.22) 27 (26.73)      
>14 17 (26.98) 26 (25.74)      
ART   0.783     
Yes 34 (53.13) 54 (50.94)      
No 30 (46.88) 52 (49.06)      
Illicit Drug Use   0.359     
Yes 3 (4.84) 2 (1.89)      
No 59 (95.16) 104 (98.11)      
Unexplained 
Diagnosis 
  0.586     
Yes 13 (20.13) 18 (16.98)      
No 51 (79.69) 88 (83.02)      
 Tubal Factor 
Diagnosis 
  0.028     
Yes 12 (18.75) 8 (7.55)      
No 52 (81.25) 98 (92.45)      
Uterine 
Diagnosis 
  0.730     
Yes 4 (6.25) 5 (4.72)      
No 60 (93.75) 101 (95.28)      
Ovarian 
Diagnosis 
  0.022     
Yes 7 (10.94) 27 (25.47)      
No 57 (89.06) 79 (74.53)      
Male Factor 
Diagnosis 
  0.278     
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Yes 8 (12.50) 20 (18.87)      
No 56 (87.50) 86 (81.13)      
PCOS Diagnosis   0.078     
Yes 10 (15.63) 29 (27.36)      
No 54 (84.38) 77 (72.64)      
Other Diagnosis   0.292     
Yes 0 (0.00) 3 (2.83)      
No 64 (100) 103 (97.17)      
Unknown 
Diagnosis 
  0.563     
Yes 17 (26.56) 24 (22.64)      
No 47 (73.44) 82 (77.36)      
Conception   0.902     
Yes 29 (45.31) 47 (44.34)      
No 35 (54.69) 59 (55.66)      
 
Specific Aim 1 Results 
1a: To estimate the effect of STI history on the probability of pregnancy. 
 Among all sub-samples, variables included in initial modeling were those 
associated with either history of STI or pregnancy (P-value<=0.20). Age and 
obesity were also included, regardless of P-value, because of their established 
association with probability of conception. History of STI was the exposure of 
interest. Using a data-based method, confounders were identified and retained in 
the model, while non-confounders were removed.  
Among the entire cohort (N=170), variables initially included were history 
of STI, age, obesity, blood pressure, race, alcohol use, smoking status, AMH 
levels, and infertility diagnoses of tubal, ovarian, PCOS, or male. The final model 
included the following variables: history of STI, age, obesity, race, ovarian 
infertility diagnosis (Table 7). In the resulting model, those with a history of STI 
had 1.56 times the odds of achieving pregnancy compared with those without a 
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history of STI, adjusted for age, BMI, race, and ovarian diagnosis. However, this 
estimate is nonsignificant (95% CI = 0.77 - 3.13).  
Among the sub-sample of women with no ART (N=82), initial variables 
included history of STI, age, obesity, blood pressure, alcohol use, race, smoking 
status, and infertility diagnoses of tubal, ovarian PCOS, or male. The final model 
only included the variables of history of STI age, obesity, blood pressure, alcohol 
use, and tubal and ovarian infertility diagnoses (Table 7). Adjusting for these 
variables, those women with a history of STI had 2.75 times the odds of 
conceiving than those without a history of STI, although not significantly (95% CI: 
0.86 - 8.77). Additionally, an effect mediation analysis was conducted on this 
specific sub-sample, as tubal infertility diagnosis was retained in the model and is 
known to be caused by certain STIs. However, when the variable was taken out, 
there was no significant change in the effect measure of STI.  
Lastly, among the sub-sample of women with ART (N=88), initial variables 
were history of STI, age, obesity, alcohol use, smoking status, AMH levels, and 
infertility diagnoses of tubal, ovarian, PCOS, and uterine. Variables retained in 
the final model included the following: history of STI, age, obesity, and race 
(Table 7). In this resulting model, those women with a history of STI had 1.19 
times the odds of achieving pregnancy than those women without a history of STI 
(95% CI: 0.46 - 3.11).  
After confounding assessments, the effect of STI on the probability of 
pregnancy among each sub-sample are shown in Table 8.  
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Table 7: Final Logistic Regression Models for the Effect of History of STI on the Probability of Pregnancy Among Each Sub-Sample 
Entire Cohort 
(N=170) 
Log (odds of Pregnancy) = β0+ β1*History of STI + β2*Age + β3*Obesity + β4*Black❊ + β5*Other Race❊+ β6*Ovarian 
Diagnosis 
No ART (N=82) 
Log (odds of Pregnancy) = β0+ β1*History of STI + β2*Age + β3*Obesity + β4*Blood Pressure2 + β5*Blood Pressure3 + 
β6*Alcohol Use + β7*Tubal Diagnosis + β8*Ovarian Diagnosis 
ART (N=88) Log (odds of Pregnancy) = β0+ β1*History of STI + β2*Age + β3*Obesity + β4*Black
❊ + β5*Other Race❊ 



















a Adjusted for age, obesity, race, ovarian infertility diagnosis. 
b Adjusted for age, obesity, blood pressure, alcohol use, tubal infertility diagnosis, ovarian infertility diagnosis. 
c Adjusted for age, obesity, race. 
 
 
Table 8: Odds Ratios for the Effect of History of STI on 
Pregnancy Among All Sub-Samples 
 OR (95% CI) P-value 
Entire Cohort (N=170)a 1.56 (0.77 - 3.13) 0.211 
No ART (N=82)b 2.75 (0.86 - 8.77) 0.088 
With ART (N=88)c 1.19 (0.46 - 3.11) 0.713 
7
2 
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1b: To estimate the effect of STI history on the time to pregnancy. 
 To determine the effect of history of STI on time to pregnancy, Cox 
models were produced for each sub-sample. Variables included in each model 
were those that were retained in the respective logistic regression models from 
Specific Aim 1a. A time-varying variable of ART per cycle was also included in 
sub-samples #1 and #3, those of which contained ART cycles.  
 Among sub-sample #1, the entire cohort (N=170), none of the variables 
tested by correlation of residuals with time, or by examining ln(-ln) curves, 
violated the Proportional Hazards assumption. When producing the Cox model, 
the interaction of ART cycles*time was significant, meaning that the time-varying 
covariate of ART violated the Proportional Hazards assumption; the final Cox 
model was stratified by the ART cycles variable. In the resulting model, women 
with a history of STI became pregnant 1.27 times faster than those without a 
history of STI. However, this estimate was not significant. Cox survival curves of 
history of STI adjusted for all variables in the model (younger than 32, not obese, 
white, no ovarian infertility diagnosis) are shown in Figure 3.  
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 In sub-sample #2, those women who never received ART (N=82), history 
of STI violated the Proportional Hazards assumption (Figure 4). No other 
variables violated the Proportional Hazards assumption. Because history of STI 
is the main exposure of interest, an extended Cox model was produced. The final 
Cox model was adjusted for all other variables included in the model and 
included Heaviside functions for history of STI before 6 months of follow-up time 
and at or after 6 months of follow-up time. Those women with a history of STI 
were becoming pregnant 5.51 times faster, significantly, than those without a 
history of STI before 6 months of follow up. From 6 months and later, those 
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women with a history of STI were nonsignificantly becoming pregnant 30% 
slower than those without a history of STI.  
 
 
 In the cohort of women who ever received ART during treatment, sub-
sample #3 (N=88), none of the constant variables violated the Proportional 
Hazards assumption. However, the ln(-ln) curves of obesity (Figure 5) were 
questionable, so an extended Cox model was produced with Heaviside functions 
dichotomized at 6 months of follow-up time. Similar to sub-sample #1, when 
ARTcycles*time was significant, and therefore the ART cycle variable violated 
the Proportional Hazards assumption. The final extended Cox model was 
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stratified by the time-varying ART covariate, adjusted for all other variables, and 
included Heaviside functions for obesity and time. Women with a history of STI 
achieved pregnancy 28% faster than those without a history of STI, though this 
was not statistically significant (HR = 1.28, 95% CI = 0.67 – 2.47). Cox survival 
curves for history of STI adjusted for all other variables (younger than 32, not 
obese, white) are shown in Figure 6. 
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 The effect of STI on the time of pregnancy among each sub-sample are 
shown in Table 9. 
Table 9: Hazard Ratios for the Effect of History of STI on Time to 
Pregnancy Among All Sub-Samples 
 HR (95% CI) P-value 
Entire Cohort (N=170)a 1.27 (0.78 - 2.06) 0.339 
No ART (N=82)b   
< 6 months 5.51 (2.09 - 12.00) <0.001 
>= 6 months 0.70 (0.19 - 2.38) 0.558 
With ART (N=88)c 1.28 (0.67 - 2.47) 0.449 
aadjusted for age, obesity, race, ovarian infertility diagnosis, ART cycles  
badjusted for age, obesity, blood pressure, alcohol use, tubal infertility diagnosis, ovarian infertility 
diagnosis  
cadjusted for age, obesity, race, ART cycles
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Specific Aim 2 Results 
2a: To determine the factors that best predict the probability of pregnancy. 
 Among all sub-samples, stepwise analysis was conducted with a P-value 
<= 0.20 for entry into the model. Age and obesity were also included, regardless 
of P-value, because of their established association with probability of 
conception. Resulting final models retained all other variables with P-values <= 
0.20.  
In sub-samples #1 (N=170) and #2 (N=82), ln(AMH) was initially included 
in model testing. However, due to missing values of ln(AMH), the resulting 
models only contained 142 and 57 observations, respectively. In both models, 
ln(AMH) was not retained. For this reason, a second model was produced that 
excluded ln(AMH) from being tested in each sub-sample. The resulting final 
models therefore contained a larger sample.  
 Among the entire cohort (N=170), the resulting final model included the 
following variables: age, obesity, ovarian infertility diagnosis, PCOS, and history 
of HPV (Table 13). Obese women had significantly reduced odds (61% lower) of 
conceiving than women who were not obese. Older women also had 19% lower 
odds of becoming pregnant than younger women, but not significantly. Women 
with an ovarian infertility diagnosis, as well as women with a PCOS diagnosis, 
had roughly 2 times the odds of conceiving than women who did not have 
ovarian or PCOS diagnoses. However, these estimates were not statistically 
significant. Similarly, women with a history of HPV had nonsignificantly 2 times 
the odds of achieving a pregnancy. Estimates for the final predictive logistic 
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regression model among sub-sample #1 are shown in Table 10. In this sub-
sample, a woman who is older than 32 (X1=1) and obese (X2=1), without an 
ovarian infertility diagnosis (X3=0), but who has PCOS (X4=1) and a history of 
HPV (X5=1), would have 1.33 odds of pregnancy. A woman with these 
characteristics would have a moderate likelihood of conceiving, with a 0.57 
probability. 
Table 10: Predictive Logistic Regression Model on 
Conception for the Entire Cohort (N=170) 
  OR (95% CI) P-value 
Age  0.549 
<32 1.00 (Referent)  




No 1.00 (Referent)  
Yes 0.38 (0.19 - 0.77)  
Ovarian Infertility Diagnosis 0.094 
No 1.00 (Referent)  
Yes 2.12 (0.88 - 5.10)  
PCOS Diagnosis  0.078 
No 1.00 (Referent)  
Yes 2.22 (0.91 - 5.34)  
History of HPV  0.136 
No 1.00 (Referent)  
Yes 2.09 (0.79 - 5.40)  
 
 Among the women with no ART (N=82), sub-sample #2, the final model 
included age, obesity, and a PCOS diagnosis (Table 13). Women who were 
older, and women who were obese, had 33% and 65% reduced odds of 
conception, respectively, than younger women and women who were not obese. 
Conversely, women with PCOS had 3.4 times the odds of conception than those 
without PCOS. None of these estimates, however, were significant. Estimates for 
the final predictive logistic regression model among sub-sample #2 are shown in 
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Table 11. A woman who is younger than 32 (X1=0) but is obese (X2=1) and has 
PCOS (X3=1), would have 1.16 odds of pregnancy. Having these would result in 
a woman having moderate likelihood of conceiving, with a 0.53 probability.  
Table 11: Predictive Logistic Regression Model on 
Conception for Women with No ART (N=82) 
  OR (95% CI) P-value 
Age  0.439 
<32 1.00 (Referent)  




No 1.00 (Referent)  
Yes 0.35 (0.12 - 1.04)  
PCOS Diagnosis  0.081 
No 1.00 (Referent)  
Yes 3.38 (0.86 - 13.30)  
 
 Among women who did receive ART (N=88), sub-sample #3, variables 
retained in the final model were age, obesity, ln(AMH), ovarian infertility 
diagnosis, and history of chlamydia (Table 13). Women with an ovarian infertility 
diagnosis had 8.3 times the odds of conception than those without an ovarian 
infertility diagnosis (P-value=0.01). Obese women had 55% lower odds of 
achieving pregnancy than women were not obese. For every one-unit increase in 
ln(AMH), the odds of pregnancy increased nonsignificantly by 41%. Those 
women with a history of chlamydia had 69% lower odds of conceiving than those 
women who did not have a history of chlamydia (P-value=0.06). Estimates for the 
final predictive logistic regression model among sub-sample #3 are shown in 
Table 12. A woman who is older than 32 years of age (X1=1), is not obese 
(X2=0), has AMH levels of 0.9 ng/mL (X3= -0.11), has an ovarian infertility 
diagnosis (X4=1), and no history of chlamydia (X5=0), would have 8.9 odds of 
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pregnancy. This combination of characteristics would result in a woman have a 
very high likelihood of pregnancy, with a 0.89 probability. 
  
 
Table 12: Predictive Logistic Regression Model on 
Conception for Women with ART (N=88) 
  OR (95% CI) P-value 
Age  0.933 
<32 1.00 (Referent)  
>=32 1.05 (0.35 - 3.13)  
Obese  0.113 
No 1.00 (Referent)  
Yes 0.45 (0.17 - 1.21)  
ln(AMH) 1.41 (0.91 - 2.20) 0.128 
Ovarian Infertility Diagnosis 0.012 
No 1.00 (Referent)  
Yes 8.28 (1.59 - 43.22)  
History of Chlamydia  0.06 
No 1.00 (Referent)  




Table 13: Final Predictive Logistic Regression Models for Probability of Pregnancy Among Each Sub-Sample 
Entire Cohort (N=170) 
Log (odds of Pregnancy) = β0+ β1*Age + β2*Obesity + β3*Ovarian Diagnosis + β4*PCOS Diagnosis+ β5*History 
of HPV 
No ART (N=82) Log (odds of Pregnancy) = β0+ β1*Age + β2*Obesity + β3*PCOS Diagnosis 
ART (N=88) 





  83 
2b: To determine the factors that best predict the time to pregnancy. 
 Predictive Cox models were produced to determine the time to pregnancy 
for each sub-sample. Variables included in each model were those that were 
retained in the respective logistic regression models from Specific Aim 2a. In 
sub-samples #1 and #3, the ART per cycle, the time-varying covariate, was also 
included. 
 Upon testing the Proportional Hazards assumption in sub-sample #1 
(N=170) via correlation between Schoenfeld residuals of variables and time, 
history of HPV violated the Proportional Hazards assumption, with a correlation 
P-value of 0.01. By examining the log-negative log curves, no other variables 
violated the Proportional Hazard assumption. Therefore, an extended Cox model 
was produced with history of HPV*time. Additionally, when producing the model 
with ARTcycle*time included, this interaction term was significant. Therefore, the 
time-varying ARTcycle variable violated the Proportional Hazards assumption, 
and the final model was additionally stratified by ARTcycles. The resulting final 
model is shown in Table 14. The only statistically significant finding was for 
history of HPV, which was associated with increased likelihood of conception, 
especially early during follow-up. Older women became pregnant 27% slower 
than younger women. Similarly, obese women achieved pregnancy 30% slower 
than non-obese women. Women with an ovarian infertility diagnosis conceived 
29% faster than women who did not have an ovarian infertility diagnosis. 
Similarly, women with PCOS became pregnant 11% faster than women without 
PCOS. Early into follow-up, women with a history of HPV were conceiving faster 
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than women without a history of HPV. At 3 months of follow-up, those with a 
history of HPV were conceiving 2.5 times faster, significantly, than those without 
a history of HPV. At 6 months, women with a history of HPV were becoming 
pregnant 37% faster than those without HPV, but not significantly. At 9 months, 
hazards are reversed, and those with a history of HPV start to become pregnant 
slower than those without HPV, and even slower at 12 and 15 months. These 
estimates, however, are not significant. In general, the effect of having a history 
of HPV is inversely related to time; those with a history of HPV conceived faster 
than those without a history of HPV early on, and as time progressed, they 
conceived slower and slower than those without a history.
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Table 14: Predictive Cox Model of Conception 
for the Entire Cohort (N=170) Stratified by ART 
per Cycle 
  HR (95% CI) P-value 
Age  0.177 
<32 1.00 (Referent) 
 
>=32 0.73 (0.46 - 1.16) 
 
Obese  0.136 
No 1.00 (Referent) 
 
Yes 0.70 (0.44 - 1.12) 
 
Ovarian Infertility Diagnosis 0.364 
No 1.00 (Referent) 
 
Yes 1.29 (0.74 - 2.24) 
 
PCOS  0.680 
No 1.00 (Referent) 
 
Yes 1.11 (0.68 - 1.82)  
History of HPV  0.038 
No  1.00 (Referent)  
At 3 Months 2.52 (1.15 - 5.56) 0.021 
At 6 Months 1.37 (0.85 - 2.22) 0.194 
At 9 Months 0.75 (0.29 - 1.96) 0.555 
At 12 Months 0.41 (0.08 - 2.12) 0.285 
At 15 Months 0.22 (0.02 - 2.36) 0.212 
 
 Upon testing the Proportional Hazards assumption for variables included 
in sub-sample #2 (N=82), no violations occurred. The final Cox model is shown in 
Table 15. Among the women who never received ART, older women conceived 
23% slower than younger women. Similarly, obese women conceived 52% 
slower than women who were not obese. Women with PCOS achieved 
pregnancy 2 times faster than women without PCOS. None of these estimates, 
however, were significant. 
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Table 15: Predictive Cox Model of Conception 
for Women with No ART (N=82) 
  HR (95% CI) P-value 
Age  0.507 
<32 1.00 (Referent)  
>=32 0.77 (0.36 - 1.66)  
Obese  0.091 
No 1.00 (Referent)  
Yes 0.48 (0.21 - 1.12)  
PCOS  0.118 
No 1.00 (Referent)  
Yes 2.09 (0.83 - 5.28)   
  
 In sub-sample #3 (N=88), all initial variables included in modeling met the 
Proportional Hazards assumption. When ARTcycle*time was included in the 
model, the estimate was significant, and therefore violated the Proportional 
Hazards assumption. The final Cox model was therefore stratified by ART per 
cycle. The final Cox model for women who ever received ART is shown in Table 
16. Among those women who ever received ART, age was not associated with 
conception rate. Obese women achieved pregnancy 28% slower than women 
who were not obese. For every one unit increase in ln(AMH), pregnancy 
occurred 9% faster; conception occurred faster with increased AMH levels. 
Those women with an ovarian infertility diagnosis were becoming pregnant 33% 
faster than women without an ovarian infertility diagnosis. Lastly, women with a 
history of chlamydia achieved pregnancy 16% slower than those without a history 
of chlamydia. None of these estimates, however, were significant. 
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Table 16: Predictive Cox Model for Women with ART 
(N=88) Stratified by ART per Cycle 
  HR (95% CI) P-value 
Age  0.987 
<32 1.00 (Referent)  
>=32 1.01 (0.53 - 1.90)  
Obese  0.334 
No 1.00 (Referent)  
Yes 0.72 (0.37 - 1.40)  
ln(AMH) 1.09 (0.88 - 1.35) 0.449 
Ovarian Infertility Diagnosis 0.427 
No 1.00 (Referent)  
Yes 1.33 (0.66 - 2.68)  
History of Chlamydia  0.644 
No  1.00 (Referent)  
Yes 0.84 (0.39 - 1.78)   
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F. DISCUSSION 
This thesis identified predictors of successful conception and assessed 
the effects of history of STI on the likelihood of conception among a cohort of 
women seeking fertility counseling. Prior evidence suggests that certain STIs, 
such as chlamydia and gonorrhea, can cause tubal factor infertility by means of 
PID [11, 12, 85-88]. However, in no studies of conception among infertile couples 
is STI a factor of conception. This study, to the best of our knowledge, is the first 
to consider and explore the effect of history of STI on the likelihood of conception 
among infertile women.  
 The findings of this study show that, among infertile women, history of STI 
has a strong positive association with likelihood of pregnancy and less time to 
achieve pregnancy. This finding is not consistent with previous literature claiming 
that certain STIs can cause infertility [11, 12, 85-88]. However, in these 
mechanisms, the STI goes untreated, and thereby causes PID and, 
subsequently, tubal factor infertility. In the current population, none of the women 
tested positive for a current STI, but rather reported having an STI in the past. 
Hence, the assumption is made that the infertile women of this population who 
have ever had an STI were able to treat the STI before PID and tubal damage 
occurred. This is supported by the effect mediation analysis between tubal 
infertility and the effect of STI on pregnancy in sub-sample #2; removing the 
variable did not affect the OR of history of STI on conception. Additionally, an 
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assumption can be made that women with a history of STI are more likely to 
have higher frequencies of coital activity, thereby increasing their likelihood of 
conception and resulting in becoming pregnant faster. However, intercourse 
frequency was not collected from our participants, and therefore could not be 
included in modeling. Future studies assessing how history of STI affects the 
likelihood of pregnancy in infertile women should include a measure of coital 
frequency. It should also be noted that the current study started with a population 
that consisted of some women who were already infertile so the progression of 
an STI could not be followed to determine a true causal relationship between STI 
and its effects on conception.  
 Among sub-sample #1 (N=170), the logistic regression and survival 
analysis are in agreement; the OR for history of STI are estimated in the same 
direction as the HR for history of STI. The same is only true in sub-sample #2 
(N=82) before 6 months, where both the odds and the hazards are greater in 
those with a history of STI; after 6 months, those with a history of STI have lower 
hazards. Likewise, among sub-sample #3, the OR and HR for history of STI 
agree: history of STI increases the odds and the hazards of pregnancy. 
 This thesis also determined which factors predict pregnancy among a 
cohort of women seeking fertility counseling. Previous studies among infertile 
women have found that factors significantly associated with pregnancy were 
secondary infertility [57, 59], shorter duration of infertility [9, 55, 57-59, 61], 
younger female age [3, 4, 6, 8, 9, 56, 57, 59], younger male age [9], higher 
sperm volume and sperm motility [5, 56], number of ART treatments [8], and 
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infertility diagnoses [2, 3] including unexplained [3, 5, 7, 8, 57, 59], male factor 
[57, 59], endometriosis [3, 57], tubal factor [2, 57], and ovarian factor [2, 7, 58]. In 
this study, however, the only factors found to be significantly associated with 
pregnancy were obesity (among sub-sample #1), which reduced probability of 
conception, and ovarian infertility diagnosis (among sub-sample #3), which was 
associated with greater likelihood of conception. Additionally, the only factor 
found to be significantly associated with the time to conception among infertile 
women was history of HPV (among sub-sample #1), which was associated with 
faster time to conception.  
 Among sub-sample #1 (N=170), the logistic regression and survival 
analysis are in agreement among all predictors. However, the OR and HR for 
history of HPV only agree during the first 6 months, where those with a history of 
HPV have increased odds and hazards of pregnancy; after 6 months, the 
hazards are higher those without a history of HPV. In sub-sample #2 (N=82), 
effect measures are in agreement; for each predictor, its respective OR and HR 
are estimated in the same direction. Likewise, in sub-sample #3 (N=82), for all 
predictors, effect measures are in agreement.  
 Interestingly, among those women who did receive ART, sub-sample #3 
(N=88), women with an ovarian infertility diagnosis had 8 times the odds of 
conceiving and conceived 33% faster than women without an ovarian infertility 
diagnosis. The question remains as to why an ovarian infertility diagnosis 
increases the odds of and decreases the time it takes to becoming pregnant. The 
answer likely lies in the fact that most ovarian diagnoses can be overcome by 
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either lifestyle changes, such as weight management, or ART, such as OI; or 
when OI fails, IVF [46].  
Additionally, among the women who never received ART, sub-sample #2 
(N=82), those with PCOS had 3 times the odds of conceiving and conceived 2 
times faster than those who did not have PCOS. Again, this is likely due to the 
fact that PCOS can achievably be overcome, and, for certain cases, requires no 
ART; obese women with PCOS can overcome their infertility with weight loss, 
while nonobese women can overcome their infertility with OI hormone pills [46].  
 It is also interesting that among sub-sample #3 (N=88), those with a 
history of chlamydia had nonsignificantly lower odds of conceiving on than those 
without chlamydia; this may be due to chance or it may be that chlamydia has a 
different anatomical impact than other STIs, such as increasing the likelihood of  
PID. 
 In descriptive analyses among each sub-sample, lower blood pressure 
was nonsignificantly associated with achieving pregnancy. It is possible that high 
blood pressure is an indicator for poor underlying cardiovascular health. 
Additionally, obesity, a known factor of infertility, is associated with hypertension 
[97]. 
 
Spontaneous Conception Rates 
In this cohort of 170 women receiving fertility counseling, there were a 
total of 41 (24.1%) spontaneous pregnancies.  
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Among the women who never received ART (N=82), there were 32 
(39.0%) spontaneous pregnancies within a cumulative follow-up time of 484 
months, for a rate of 6.61 pregnancies every 100 months. The 3-year risk for 
spontaneous pregnancy would be calculated to be 90.7%. However, this is 
assuming that fecundability of the population remains constant through time, 
when in reality, fecundability decreases over time as the more fertile women are 
removed from the sample. Other studies among untreated infertile women report 
3-year spontaneous conception rates at 24.9% [59], 38.2% [57], and 72.0% [58]. 
The much larger probability of pregnancy reported here could be explained by 
the fact that our sample likely has higher fecundability than other studies of 
women seeking fertility treatment.  For example, we did not require women to 
meet any definition of infertility in order to be included in the study.  In fact, of the 
82 women who remained untreated by ART, 35 (42.6%) had an unknown 
infertility diagnosis, which was not considered in other studies.  
Among the women who did receive ART (N=88), 9 (10.2%) women 
achieved a spontaneous pregnancy within a cumulative follow-up time of 483 
months, for a rate of 1.8 spontaneous pregnancies every 100 months. With this 
rate, a 5-year risk for spontaneous conception would be 66.0%, again making the 
strong assumption of constant fecundability over time for all women who did 
receive ART. One study reported a 5-year live-birth after spontaneous 
conception rate of 18.1% [60]. Another study, however, reported a 5-year 
spontaneous conception rate of 60.2% [9]. However, that study only included 
women with an unexplained infertility diagnosis, whereas the current sub-sample 
  93 
consisted of 25 (28.4%) women with an unexplained infertility diagnosis. 
Unexplained infertility is an infertility diagnosis related to the strongest likelihood 
of pregnancy. These results are comparable to the current study’s report of 
66.0%, as the population used in the current study is probably more fertile than 
most other populations.  
 
Strengths and Limitations 
 The LOUSSI Study is longitudinal and prospective in design. One strength 
of the design is the ability to lower and potentially eliminate the amount of recall 
bias from participants. Follow-up with participants occurred starting at 6 months 
post-enrollment and will continue every 6 months. With short follow-up intervals, 
there is a small likelihood of women forgetting their conception date or how long 
they continued trying to conceive. Additionally, the study design allows the 
collection of time and any wanted time varying covariates, making survival 
analyses and Cox models possible to produce; therefore, measures of effect are 
more accurate than without time data.  
 Another strength of the study is the retention rate. Of the original 264 
participants, follow-up data was collected for 170 (64.4%). However, of the 
participants that consented to being recontacted (n=157), follow-up data was 
successfully collected 128 (81.5%) of them, with 42 (40.0%) additional follow-up 
data via medical records for those who did not consent to being recontacted 
(n=105).  
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 There are several limitations to the current study, with the most obvious 
being the sample size. The small sample of 170 has the potential to create low 
power and imprecise measures of effect, which is evident, as several of the 
reported ORs and HRs have wide confidence intervals. Additionally, given the 
small sample size, the reported estimates of effect measures by have been 
totally left up to chance.  
 Selection and misclassification bias were likely present in this study. In the 
recruitment phase of the study, physicians of the REI clinic were ‘gatekeepers’ of 
the study and determined which of their patients they recommended participating 
in the LOUSSI Study. This filter led to only a portion of eligible women being 
invited to enroll  into the study. Additionally, selection bias likely occurred in the 
recontact phase, as women who had achieved a pregnancy were probably more 
likely to be successfully recontacted. This bias would lead to elevated conception 
rates being reported. In addition, the main predictor for specific aim 1 was history 
of STI, which was a self-reported variable and likely suffered from some 
misclassification. It is likely that some women who ever had a history of STI did 
not report it, either intentionally or otherwise. Additionally, unless collected via 
medical records, pregnancy data was also a self-reported variable. The potential 
misclassification of these variables would result in inaccurate estimates of effect 
measures. 
 Another limitation that should be noted is that the time data was collected 
by months, and not by menstrual cycles. Some women have irregular 
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menstruation, and cycle length varies from woman to woman; therefore using 
follow-up time in months does not accurately reflect the number of cycles at risk.  
 In terms of fertility diagnoses, the cohort of women used for this study was 
not comparable to other populations assessed in conception studies. Multiple 
women in the LOUSSI Study were diagnosed with more than one infertility 
diagnosis, with some having up to three diagnoses. In other studies, women 
typically have one diagnosis; making it possible to determine effect estimates of 
each diagnosis, relative to one other reference diagnosis. However, in this study, 
effect estimates for diagnoses could only be determined by comparing those with 
a specific diagnosis to those without the same diagnosis.  
Additionally, most other studies assess very specific populations, whether 
they be truly infertile, diagnosed with a certain infertility diagnosis, or by their 
treatment methods. The women in the LOUSSI Study were relatively 
heterogenous compared to other studies, in that some women had no infertility 
diagnosis and in the women’s treatment methods could vary over time – whether 
by type of treatment or by status of treatment. With this heterogeneity interpreting 
effect estimates should be done cautiously; such varying data makes it difficult to 
produce accurate effect estimates.  
  
Suggestions for Further Research 
 In future efforts assessing how history of STI affects the likelihood or time 
to conception, coital frequency should be collected, as the frequency of 
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intercourse could be a key confounder in the relationship between history of STI 
and achieving a pregnancy.  
 Additionally, future studies should make great efforts to collect time data 
by menstruation cycles, and not in months, as some women do not have regular 
periods. This can be accomplished by collecting daily urine samples and 
measuring levels of reproductive hormones such as LH.  Access to medical 
records is also an imperative part of a fertility study; access to detailed records of 
ART treatments, clearly defined diagnoses, and conception dates eliminate the 
potential for misclassification and recall bias. Daily diaries can ideally be used to 
record intercourse, menstruation and time-varying variables such as alcohol and 
smoking.
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G. SUMMARY AND CONCLUSION 
This thesis aimed to identify predictors of pregnancy and the effect of STI 
history on probability of conception in a population of women seeking fertility 
counseling.  This population was not a homogeneously infertile population, and 
24% conceived naturally during follow-up. Obesity, the type of infertility 
diagnosis, and history of HPV were significant predictors of pregnancy in this 
small study. History of STI was associated with higher odds of pregnancy and 
shorter time to pregnancy, nonsignificantly however, regardless of ART 
treatment. This may be due to confounding by coital frequency; future studies of 
STI history and conception should make efforts to record intercourse frequency 
in a prospective manner. 
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